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Abstract 
Abstract of thesis entitled: 
Identification of genetic abnormalities in nasopharyngeal carcinoma by comparative 
genomic hybridization and interphase cytogenetics 
Submitted by： Fan Chung Sze 
Degree： Master of Philosophy in Medical Sciences 
University： The Chinese University of Hong Kong 
Month/ Year: July /1999. 
Nasopharyngeal Cardnoma (NPC) is a malignant disease that is 
prevalent in Southern China, including Hong Kong. Etiological studies have 
suggested that Epstein-Barr (EBV) infection, inherited genetic susceptibility 
and environmental factors, are causative factors. Despite previous 
cytogenetic and molecular studies demonstrated frequent losses on 
chromosomes 3p, 9p, 11q, 13q and 14q in NPC, the overall genetic changes 
involved are still not well understood. 
In this study, as a first step in the genetic characterization of NPC, the 
NPC genome for chromosomal abnormalities was surveyed. Comparative 
genomic hybridization (CGH), a molecular cytogenetic technique that allows 
the screening for regions of DNA sequences losses, gains and amplifications 
in the entire tumor genome, was employed in this part of the investigation. 
This was followed by further elucidation of candidates genes involvement by 
interphase fluorescence \n-situ hybridization (FISH) were employed. 
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CGH analysis was attempted on 17 NPC biopsies, as well as three 
NPC cell lines and three xenografts. A complex pattern of chromosomal 
imbalances was revealed from cell lines and xenografts with recurrent gains 
on chromosomes 7 and 8, but no apparent aberration was found in all 17 
NPC biopsies. Extensive infiltration of benign lymphocytes in NPC samples 
was suspected to be the major hindering factor for CGH analysis. Tissue 
microdissection was then applied on 11 NPC biopsies, and a source of 
relatively purer tumor DNA was obtained. Whole genome amplification by, 
degenerate oligonucleotide primed polymerase chain reaction (DOP-PCR) 
was performed on the small amount of DNA recovered prior to CGH. CGH 
analysis revealed that the most common copy number increases were on 
chromosomes 12q (9/11 cases; 82%), 6p, 11q13, 15q (8/11 cases each; 
73%)，1q, 3q, 8q and 12p (7/11 cases each; 64%). The smallest overlapping 
regions were defined to 12q13, 6p21.2, 6p22, 11q13, 15q22-q23, 1q21, 
3q26.3-qter, 8q12-q21.1, 8q23.2-q24.12 and 12p12. The most frequent 
losses were on chromosomes 11q14-qter (8/11 cases; 73%), 14q (6/11 
cases; 55%), 3p and 9p (5/11 cases; 45%). The minimal overlapping sites 
were on 11q21-q23, 14q31, 3p12-p14, 3p24-pter, and 9p22-pter The CGH 
results were consistent with previous CGH and LOH studies in NPC. Several 
genetic imbalances, such as gains of 6p and 15q, however, were not 
described in NPC and represented novel findings. 
Based on the CGH results on NPC cell lines, xenografts, and primary 
tumors, gains of chromosomes 7’ 8 and 11 were further investigated on a 
series of NPC paraffin-embedded tissue sections by interphase FISH using 
three enumeration probes (a-satellites 7, 8 and 11). Also, the possible 
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involvement of protooncogenes c-myc (8q24) and lnt-2 (11q13) on these 
chromosomes was also assessed. Gains of a-satellites 7，8 and 11 were 
observed in 27%, 43%, and 25% respectively, while polysomy of c-myc and 
lnt-2 were found in 60% and 75% in this NPC series. The interphase FISH 
analysis not only confirmed the CGH findings but also presented, for the first 
time, the involvement of these protooncogenes in NPC. Overall genetic 
pattern identified provided the entry points for further investigation in 
understanding the pathogenesis of NPC. 
















在 CGH 分析之前收少量 DNA 用 DOP-PCR (Degenerate Oligonucleotide 
Primed Polymerase Chain Reaction)技術擴增全基因組。CGH分析結果顯示： 
考貝數增加最多的是在染色體12q (9/11病例；82%)、 6p、 l l q l 3 . 15q 
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(8/11病例；73%)、 Iq、3q、8q、和121) (7/11病例；64%)。最小重 
區位於 12ql3、 6pll.2. 6p22. l lq l3 . 15q22-q23. lq2K 3q26.3-qter. 
8ql2-q2U 8卩23.2-924.2、和 12pl2。缺失頻率最高的是染色體 llql4-qter(8/ll 
病例；73%)、149(6/11病例；55%)、3?和9?(5/11病例；45%)。最小 





果 ’ 7、8和11染色體增加，用間期FISH技術以三種a-衛星DNA (7、 
8、11)爲探針，對一系列石腊包埋組織切片做進一步研究。同時對染色體 
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Chapter 1 Introduction 
1.1 Nasopharyngeal Carcinoma (NPC) 
NPC is a prevalent cancer amongst the Southern Chinese, with the 
highest incidence being found in the Guangdong Province (25-50/100,000 
population per year) (Ho 1978). In contrast, NPC is rare in the Caucasians 
with an incidence of less than 1 per 100,000 a year (Hildeshim & Levine, 
1993). A relatively lower incidence (15-20/100,000) in comparison to the 
Southern Chinese is also noted among the Maghrebin Arabs populations in 
Northern Africa, and Eskimos in Greenland and Alaska. 
Hong Kong is geographically located within the high-risk area. 
According to the Department of Health Annual Report 1997/98, NPC is 
ranked the sixth "cancer killer", causing more than four hundred deaths a 
year Approximately, 800 to 1,000 new cases are diagnosed every year, 
being two to three times more commonly seen in males than females. 
1.1.1 Histology of NPC 
Anatomically, the nasopharynx is a small space situated at the back of 
the nasal cavities and above oropharynx, and immediately below the base of 
skull. NPC is the neoplasm that arises from the epithelial lining of the 
nasopharyngeal wall. Histopathologically, NPC is classified into three 
categories, according to the World Health Organization OA/HO) classification. 
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Type I: Squamous Cell Carcinoma 
A carcinoma showing definite evidence of squamous differentiation and / or 
intercellular bridges. Depending on the degree of differentiation, the 
squamous cell carcinoma can be further divided in 3 grades, which include 1) 
well differentiated, 2) moderately differentiated, 3) poorly differentiated. 
Type II: Non-keratinizing Carcinoma 
The tumor cells have moderately well defined cell margins and show a 
stratified or pavement arrangement. 
Type III: Undifferentiated Carcinoma 
The tumor cell margins are indistinct. The cells are arranged either as 
irregular and moderately well defined mass. 
Among these, Type III is the most common category of NPC found in 
Hong Kong. 
1.1.2 EtiologicalFactors 
Since NPC has a distinct geographical-ethnic distribution, it has drawn 
much attention from cancer researchers. Investigations have suggested that 
Epstein-Barr virus (EBV) infection, inherited genetic susceptibility and 
environmental factors are the major etiology factors. 
I) EBV Infection 
EBV is a herpesvirus carrying a double-stranded DNA genome. 
Evidenc:e from both serological and molecular biology studies has suggested 
a strong association between NPC and EBV infection. 
1- 2 
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a) Serological Evidence 
The titers of immunoglobulin lgG and lgA against the EBV capsid 
antigen, early antigen diffuse component, and anti-EBV nuclear antigen 
(EBNA) complex are often elevated in NPC patients (Kottaridis et al, 1996; 
Fandi et al, 1994; Liebowits, 1994). Currently, some of these antibody 
profiles are used as tumor markers for diagnosis of NPC. 
b) Molecular Biology Evidence 
Molecular biology studies have showed that EBV DNA and its gene 
products are consistently detected in NPC tissues. The EBV genome has 
been virtually found in all undifferentiated NPC (Choi et al, 1993; Niedobitek, 
1991; Murono et al, 1997). Also, EBV DNA in NPC samples is clonal, 
suggesting its origin from a single EBV infected cell. This observation, 
together with the presence of EBV in premalignant nasopharyngeal lesions, 
indicate that EBV infection plays an oncogenic role in NPC and is an early 
event in oncogenesis (Pathmanathan et al, 1995). 
Recently, Lo et al (1999) reported a high frequency (96%) of cell-free 
EBV DNA detected in the plasma of patients with NPC by real-time 
quantitative PCR. The level of plasma of EBV DNA was found to be higher in 
patients with advanced-stage NPC than early stage. 
Apart from EBV DNA, the small nuclear EBV-encoded RNAs, EBERs, 
are also regularly expressed in NPC. Other RNA transcripts like latent 
membrane proteins (LMP1, LMP2A and LMP2B) are also present but at a 




lmmunohistochemical studies on viral gene expression have revealed 
that EBNA-1, a nuclear protein, is invariably present in NPC cells, while LMP-
1 is expressed in about 65% of this tumor (Niedobitek, 1992; Hu et al, 1995). 
EBNA-1 plays an important role in the viral replication and maintenance of 
viral genome during cell division, while LMP-1 has been shown to have 
potent growth-altering effects in vitro (Fahraeus et al. 1990). 
II) Inherited Factors 
The incidence of NPC in Southern Chinese is almost 100-fold higher 
than most Caucasian populations. The risk of developing NPC in 
Southern Chinese remains high even when they migrated to non-endemic 
regions (Yu et al, 1981). The difference in genetic make-up may be a 
possible explanation of the disparity. Evidence has shown that there is an 
increased relative risk of NPC development in those siblings sharing a similar 
histocompatibility leukocyte antigen (HLA) haplotypes as the affected family 
member (Chan et al, 1983 & 1990). Specifically, the joint inheritance of HLA 
A2 and HLA Bsin2 on the same chromosome confers a higher risk for NPC 
(Simons et al, 1976). In addition, haplotypes Aw19, Bw46 and B17 are also 
associated with an increased risk. A11, on the other hand, is associated with 
a decreased risk of NPC development. It has been postulated that different 
haplotypes are associated with different immunological response to EBV 
infection. 
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III) Environmental factors 
The geographic distribution of NPC may also be a consequence of 
environment or cultural factors. Certain traditional southern Chinese foods, 
such as salted fish, preserved vegetables, salted duck eggs and shrimp 
paste, contain carcinogenic components, such as volatile nitrosamines (N-
nitrosodimethylamine and N-nitrosodiethylamine). The carcinogenicity of 
salted fish has been demonstrated in mice, which developed malignant 
tumors of nasal cavity as a result of salted fish diet (Huang et al, 1978). 
Besides dietary factors, dust smoke, chemical fumes (Ho, 1978; Yu et 
al，1990 & 1991; Armstrong, 1983; Ning, 1990)，herbel medicines (lto et al, 
1981) and inhalation of tobacco smoke (Shanrungaratnam, 1978; Yu, 1990) 
had also been identified as possible etiological factors in epidemiological 
studies. 
1.1.3 Genetic Changes in NPC 
Cancer development is associated with the acquisition and 
accumulation of genetic changes, coupled with waves of clonal expansion. 
Genetic alterations can occur at the chromosomal level (gains, losses or 
rearrangements), gene level (activation of oncogenes or inactivation of tumor 
suppressor genes) and nucleotide level (mutation). These changes have 
been studied in NPC by various techniques. 
I) Cytogenetic Findings 
Conventional cytogenetic analysis provides a global view on numerical 
and structural aberrations present. Karyotyping on NPC has, however, been 
1-5 
hitroduction 
limited by the sub-optimal growth of NPC tissue in vitro and poor morphology 
of metaphase spreads that precluded accurate analysis. Thus far, there has 
been only two reports on the cytogenetics of primary NPC by conventional 
cytogenetic analysis. A consistent marker of "add chromosome 5q" with a 
breakpoint at q31 was observed in five out of 14 NPC biopsies karyotyped 
(Kristensen et al, 1991). Huang et al (1989) have also studied eight NPC 
biopsies and found partial deletions on 1p (2/8), 3p (3/8) and 12 (3/8). 
Much of the cytogenetic information on NPC has been derived from 
NPC cell lines and xenografts. Thus far, near 20 human NPC cell lines and 
xenografts have been karyotyped. Chromosome number in these cell lines 
and xenografts ranges from hypodiploidy to hypertetraploidy. The karyotypes 
were frequently complex, and associated with both numerical and structural 
aberrations. Many marker chromosomes of uncertain origins were also 
identified. Nevertheless, frequent chromosomal losses were observed on 
chromosomes 1p, 3p, 9p, 11q, 13q, 14q, 16q and X，while copy number 
gains of chromosomes 1，2 and 9 were found. 
The occurrence of non-diploid status of NPC has been further 
supported by a flow cytometry study. The rate of hyperdiploidy and 
hypodiploid in 101 NPC patients studied was 37% and 1% respectively. 
Also, non-diploid status was demonstrated in 7 out of 12 (58%) patients with 
recurrent NPC (Zhao et al, 1994). 
II) Molecular Findings 
Allelic imbalances in NPC have been investigated by molecular 
analysis. To date, only one genome-wide allelotyping of loss of 
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heterozygosity (LOH) has been reported (Mutirangura et al, 1997). Other 
LOH studies on NPC have focused on individual chromosomes. Frequent 
allelic losses have been found on 3p, 9p, 11q, 13q, and 14q. These 
chromosomal changes in NPC, together with several common oncogenes 
and tumor suppressor genes (TSGs) studied are reviewed as follow: 
a) Chromosome 3p 
Huang et al (1989) have demonstrated consistent LOH on 
chromosome 3p using Southern blot analysis. Using mircosatellite 
polymorphic markers, allelic loss on 3p has been found in 67-78% primary 
NPC (Lo et al, 1994; Hu et al, 1996; Mutirangura et al, 1997; Deng et al, 
1998). Three regions of deletions, 3p13-14.3, 3p14.3-21.1 and 3p25-26.3, 
have been identified. The multiple deleted regions on 3p suggested the 
possibility of more than one TSGs residing on this chromosomal arm being 
involved in NPC tumorigenesis. 
The presence of TSG on 3p (3p21) has been confirmed by a 
functional assay. Tumor suppressive activity was restored in an NPC cell 
line，HONE-1, after receiving fragments of normal 3p fusion (Cheng et al, 
1998). 
Candidate TSGs on 3p include fragile histidine triad (FHIT) gene at 
3p14.2, and von Hippel Lindau (VHL) gene at 3p25. Homologous deletion of 
FHIT has been identified in two NPC cell lines (Ohta et al, 1996). By 
polymerase chain reaction single strand-conformation polymorphism (PCR-
SSCP) and direct DNA sequencing, neither mutation nor aberrant 
methylation of VHL gene has been detected in NPC tumor samples and cell 
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lines. Thus, VHL gene may not be involved in NPC tumorigenesis (Sun et al, 
1995). 
b) Chromosome 9p 
LOH on chromosome 9p in NPC, ranging from 61% - 87%, have been 
detected from various studies (Huang et al, 1994; Mutirangura et al, 1997). 
The common region of deletion identified was 9p21-22, where candidate 
TSGs p16, p15 and p19/ARF are located. Further investigations suggested 
that inactivation of p16 gene is common in NPC. This might due to 
homozygous deletion, aberrant methylation of the 5'CpG island, or intragenic 
mutation. Of these, homozygous deletion and aberrant methylation comprise 
the majority of inactivation events in NPC. Since p16 is a negative regulator 
at the G1/S boundary in the cell cycle, loss of p16 function may lead to cell 
progression and proliferation (Liggett et al. 1998). No abnormality of p15 and 
p19/ARF\Nas found in NPC (Lo et al, 1997). 
c) Chromosome 11q 
LOH on chromosome 11q have been reported in about 46-54% of 
primary NPC (Hui et al, 1996; Mutirangura et al, 1997). Two distinct deletion 
regions, 11q13.2-22 and 11q22-24, were identified. A higher frequency of 
allelic loss was found on 11q23 than on 11q13 region by both groups. It is 
known that Ataxia Telangiectasia mutated (ATM) gene is located within the 
region 11q22-24. The ATM gene is involved in Ataxia Telangiectasia 
syndrome, which is characterized by the DNA repair deficiency and cancer 
predisposition (Gatti et al, 1991). The involvement of this gene in NPC, 
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however, remains to be elucidated. Although 11q13 is a frequent site of 
chromosomal amplification in many tumors, such as head and neck 
squamous cell carcinoma (Bockmuhl et al, 1996; 1998), amplification of 
11q13 in NPC has been demonstrated to be a rare event by multiplex PCR 
analysis (Huiet al, 1996). 
d) Chromosome 13q 
A high frequency of LOH on 13q has been identified at a locus 
proximal to 13q14.3 (Mutirangura et al, 1997), where two known TSGs 
reside. They are the retinoblastoma (Rb) gene at 13q14 and the familial 
breast cancer syndrome (BRCA2) gene at 13q12. Molecular studies on NPC 
biopsies and cell lines have demonstrated no point mutation in the hot-spots 
of Rb gene. Also, deletion in the promoter region of Rb or DNA sequences 
losses or rearrangement has not been detected. Moreover, the expression of 
Rb has been within the normal range. All these negative results suggested 
that Rb gene alteration is unlikely responsible for NPC development (Sun et 
al，1993; Lin et al, 1992). The role of BRCA2 in NPC carcinogenesis 
remained to be investigated. 
e) Chromosome 14q 
LOH on chromosome 14 in NPC has also been reported at a rate up 
to 74% (Mutirangura et al, 1997 & 1998; Cheng et al, 1997). Mutirangura et 
al have mapped three minimal deleted regions, 14q11.2, 14q12-13 and 
14q32-qter, while Cheng et al have identified common allelic loss on 
14q24.3-32.1. These findings suggested that more than one TSG reside on 
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14q. Allelic imbalance on 14q11.2 has been linked to T-cell receptor delta 
chain (TCRD) locus, which may be a consequence of chromosomal 
rearrangement. LOH of regions 14q12-13, 14q24-32 and 14q32-qter 
overlapped with the loci of TSGs found in ovarian carcinoma (Bandera et al 
1997), meningioma (Simon et al, 1995) and bladder carcinoma (Chang et al, 
1995) respectively. 
f) Alterations on other chromosomes 
Other allelic losses in NPC have been identified on 16q (47.8%), 22q 
(45.4%), 19p (36%) and 17p (30%) (Mutirangura et al, 1997). 
Common TSGs and oncogenes 
Some common TSGs, such as p53 and WAF1, and several well-
known oncogenes, like c-myc, bcl-2 and ras have been investigated in NPC. 
Aberrant changes of these genes or their products are suspected to be 
important to NPC development. 
p53 
TSG p53, located on 17p13.1, encodes a transcription factor inhibiting 
cell cycle progression in response to DNA damage and mediating program 
cell death, lnactivation of p53 is one of the most common genetic changes in 
human cancers. However, several earlier studies, utilizing LOH and PCR-
SSCP assays, revealed mutation or deletion of this gene in primary NPC has 
been rare (0%-10%) (Lo et al, 1992; Spruck III et al, 1992; Sun et al, 1992). 
Recently, a relatively higherfrequency ofp53 mutation (3/11) has been found 
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in NPC cases studied by yeast functional assay (Lung et al, 1998). By 
immohistochemical analysis, elevated p53 protein expression has been 
detected in as much as up to 95% of primary NPC cases studied (Sheu et al, 
1995; Leung et al, 1998; Gulley et al, 1998). The low mutation rate, plus the 
aberrant expression of p53, indicated p53 inactivation is probably not via 
gene mutation, but dysfunction of its protein instead. 
Previous studies have shown that p53 may be inactivated by 
complexing with viral oncoproteins (Yew et al, 1992). Since EBV is closely 
associated with NPC, several of its proteins, such as EBNA-5 and BZLF-1, 
have been hypothesized as p53-interfering factors (Gulley et al, 1998). 
However, further experiments are needed to confirm the role of these viral 
proteins in the p53 inactivation and tumorigenesis. 
WAF1 
TSG WAF1 gene, mapped on 6p21, encodes the p21 protein, which 
binds and blocks the activity of cyclin-cdk complexes, and negatively controls 
the progress of cell cycle from G1 phase to S phase. No gross gene 
alteration or point mutation of this gene has been detected in primary NPC 
(Sun et al, 1995; Qian et al, 1995). 
c-myc 
Oncogene c-myc is a member of myc gene family and resides on 
8q24. Its gene protein, p62, is a nuclear protein promoting cell proliferation 
and inducing apoptosis. By immohistochemistry, c-myc overexpression has 
been detected in 37/41 NPC samples (90%) and correlated with a poor 
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clinical outcome (Porter et al, 1994). A similar finding has been 
demonstrated in NPC cell lines using Northern blotting analysis, however, no 
rearrangement or alteration of c-myc gene has been identified (Lin et al, 
1993). 
bcl-2 
B-cell leukemia/ lymphoma-2 (bcl-2) is mapped on 18q21 region. It 
encodes for an inner mitochondrial membrane protein, which enhances cell 
survival by inhibiting apoptosis. High level of bcl-2 protein has been detected 
in 80% of NPC samples analysed by in situ hybridization, immohistochemical 
and immuoblotting techniques (Lu et al, 1993). Translocation of 
chromosomes t(14;18)(q32;q21), which is common in follicular lymphomas, 
has not been detected in NPC by PCR analysis that amplified the bc/-2-JH 
juctures (Harn et al, 1996). 
ras 
The ras family includes H-ras, K-ras, and H-ras, which are located on 
11p15.1, 12p12.1 and 1p13 respectively. Oncoprotein of ras, 21 kDa, 
possesses GTPase activity and plays a key role in signal transduction 
pathway leading to cell proliferation and transformation. Overexpression of 
ras protein was identified in 31/41 (76%) of primary NPC by immunostaining 
(Porter et al, 1994). However, mutation of ras gene in NPC was 




MDM2 oncogene resides on 12q14.3-15 region and encodes a p90 
protein, which inactives the function of p53 by binding to the transactiving 
domain of p53. Amplification of the MDM2 gene was, however, detected only 




1.2 Background of Present Study 
Previous cytogenetic and molecular studies on NPC have mainly 
indicated areas of recurrent genetic losses. Information on chromosomal 
gains, on the other hand, has been little. In addition, previous studies on 
several well-known TSGs, such as Rb, and oncogenes, such as MDM2, have 
suggested their involvement in NPC to be rare. Hence, the molecular basis 
underlying the initiation and progression of NPC remains uncertain. Thus, 
the identification NPC-related TSGs and oncogenes would be of importance. 
The first step would be to survey the whole NPC genome for overall 
chromosomal aberrations. 
Comparative genomic hybridization (CGH) is a relatively new 
molecular cytogenetic technique. It allows the identification of chromosomal 
gains and losses in the entire tumor genome without the prior knowledge of 
the aberrations present. Therefore, it is possible to reveal novel sites of 
genetic alteration in tumor. Interphase cyotgenetics is the application of 
fluorescence in situ hybridization (FISH) on interphase nuclei. Using relevant 
probes, genetic aberrations, such as aneuploidy and gene amplification, in 




1.3 Aims of Study 
1. To survey the tumor genome regions of DNA sequences gains and losses 
in nasopharyngeal carcinoma by CGH. 
2. To investigate recurrent chromosomal gains identified by CGH by 
interphase cytogenetics on a large series of NPC tissue sections. 
3. To investigate the possible involvement of candidate oncogenes on the 
affected chromosomal arms. 
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Chapter 2 Comparative Genomic Hybridization and 
Fluorescence ln-Situ Hybridization 
2.1 Introduction 
Conventional cytogenetic study plays an important role in both clinical 
service and basic research, where it provides an overview on all numerical 
and structural aberrations present. In cancer studies, conventional 
cytogenetics has proved its usefulness in the diagnosis and prognosis in 
haematological malignancies. Karyotyping on solid tumors, however, is 
frequently hampered by the suboptimal tumor growth in vitro, poor quality of 
metaphases and the complex nature of chromosomal changes. This results 
in limited cytogenetic information in solid tumors. 
Leaps of progress have followed steps of technical innovation. With 
the emergence of molecular cytogenetic techniques, the detection of genetic 
aberrations, especially in solid tumors, has become greatly enhanced. They 
provide a powerful linkage between molecular genetics and conventional 
cytogenetics, as they can pinpoint aberrant chromosomal regions at the 
molecular levels. Two major molecular cytogenetic techniques, fluorescence 
in situ hybridization (FISH) and comparative genomic hybridization (CGH), 
have been employed in this study. The principles and applications, as well 
as their advantages and limitations are introduced and discussed in this 
chapter. 
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2.2 Fluorescence In Situ Hybridization (FISH) 
2.2.1 Principle of FISH 
FISH was introduced by Pinkel et al in 1986. As its name implies, 
FISH employs DNA probes, labeled with fluorochrome or hapten molecule 
which can in turn be tagged by a fluorescent dye. it detects structural and 
numerical chromosomal abnormalities, as well as the localization of genes on 
specific chromosomes. Labeled DNA probe is denatured and introduced 
onto target DNA, which can be fixed metaphase chromosomes or interphase 
nuclei. Based on the principle of recombinant DNA, hybridization occurs, in 
which homologous sequences of single-stranded target DNA anneal to the 
complementary probe. After post-hybridization washing and detection 
procedures, the occurrence of specific chromosomal aberrations can be 
visualized and scored on the basis of copy number or the spatial relation of 
hybridization signals under fluorescence microscope. A schematic diagram 
is illustrated in Figure2.1. 
2.2.2 Applications of FISH 
To date, there is a variety of DNA probes available for the applications 
of FISH in both medical diagnosis and basic research. These probes can be 
categorized into: 
I) Repetitive sequences probes 
") Unique sequences probes 
III) Chromosome painting probes 
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I) Repetitive Sequences Probes 
A major type of repetitive sequences probes is the satellite probe, a or 
P. which consists of tandemly repeated sequences that targeted the 
chromosome-specific peri-centrometic region. Since the target region is 
considerably large, the signal obtained is usually easier to detect. It is 
particularly useful in interphase cytogenetics for the detection of 
chromosomal aneuploidy，such as trisomy and monosomy. For example, 
using a-satellite probes on interphase nuclei, trisomy 7 and monosomy 18 
have been frequently detected in colon carcinoma (Herbergs et al, 1994; 
Sasaki et al, 1995). 
II) Unique Sequences Probes 
Gene specific probes that are targeted to unique stretches of the 
genomic DNA. The size of probes varies from one to hundreds kb. It allows 
copy number changes and localization of gene to be visualized under 
fluorescence microscope. These probes also allow the detection of precise 
chromosome breakpoints that are far beyond the resolution of conventional 
banding technique. The detection of oncogenes amplifications, gene 
deletions or fusions is applicable in both interphase nuclei and metaphase 
spreads_ Using region specific probe, amplification of HER-2/neu gene has 
b ^ n demonstrated in paraffin-embedded sections of breast carcinoma 
(Press et al, 1997). 
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III) Chromosome Painting Probes 
Chromosome painting probes are chromosome-specific and are able 
to colorize the entire chromosome. With the aid of these probes, detection of 
marker chromosomes and complex chromosomal rearrangement present in 
tumor metaphases becomes feasible. Structural abnormalities, like 
translocations and insertions, can therefore be identified. Using chromosome 
specific probes, t(1;13) translocation was demonstrated in a medulloblastoma 
cell line (Bigner and Schr6ck, 1997). 
2.2.3 Advantages and Limitations 
In comparison with conventional cytogenetics, FISH technique is 
faster and less laborious. Also, it detects numerical and structural 
chromosomal abnormalities with a higher specificity and sensitivity. Using 
different probes labeled in specific fiuorochrome or fluorochrome 
combinations, simultaneous detection of multiple target regions is possible. 
The number of permutations can be more than 24 different colors (Tank et al, 
1995). Indeed, a newly developed molecular cytogenetic technique, spectral 
karyotyping (SKY), employs a concoction of fluorescent dyes that allows the 
painting of the 23 pairs of human chromosomes in different colours. SKY 
allows the elucidation of uncertain marker chromosomes and complex 
chromosomal structures, which may not be identified by traditional banding 
analysis. Moreover, SKY can avoid ambiguous interpretation of subtle 
changes and minimize the influence of subjectivity. 
Besides being able to be applied on metaphase chromosomes, FISH 
can be applied on non-dividing interphase cells from various sources, such 
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as fresh, frozen or even paraffin-embedded tissues, thereby extending the 
range of samples available for investigation. 
Cell culture and good-quality metaphases are necessary in 
conventional cytogenetics, but extremely difficult to archive, particularly in the 
analysis of solid tumors. The interphase FISH cytogenetics opens a window 
of opportunity for study. 
Nevertheless, there are certain difficulties in the application of FISH 
interphase cytogenetics. Prior knowledge of aberrations of the tumor is 
required to determine the choice of probe used. Although various probes are 
readily available, they are nonetheless expensive. In addition, scoring of 
FISH signals is a laborious task OA/olf et al, 1997). Also, interphase FISH is 
difficult if multiple probes were employed. 
The drawback of chromosome painting is that the analysis requires 
metaphases. Also, the sensitivity of detecting intra-chromosomes changes, 
such as inversion or micro-deletion is lower than inter-chromosomal 
abnormalities (Ried et al, 1998). 
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2.3 Comparative Genomic Hybridization (CGH) 
2.3.1 Principle of CGH 
CGH is a molecular cytogenetic technique and was developed by 
Kallioniemi et al in 1992. It allows a comprehensive analysis of relative copy 
number changes of DNA sequences in the entire tumor genome in a single 
experiment. The principle of CGH is based upon a copy number karyotype 
(Kallioniemi et al, 1992)，in which DNAs from malignant and normal cells are 
compared. Equal amount of differentially labeled tumor DNA and normal 
DNA, together with excess amount of unlabeled human Cot-1 DNA, are 
mixed as a probe for chromosomal in situ suppression hybridization on 
normal metaphase spreads. Since interspersed repetitive sequences 
present in the genome can cause cross-hybridization and interfere with signal 
intensities, excess human Cot-1 DNA is included in the probe to suppress 
these sequences. Homologous chromosome-specific DNA sequences 
present in both test and reference DNA will compete for the same target 
chromosome. Tumor DNA from chromosomal regions that are present at 
increase copy number bind relatively more than normal DNA at these 
regions, whereas DNA from regions that are deleted binds relatively less. 
The tumor DNA is commonly labeled with a green fluorochrome and 
reference DNA is labeled with red fluorochrome (Kallioniemi et al, 1992 & 
1994). Using fluorescence microscopy and digital image analysis system, 
the fluorescence ratio of green-to-red is calculated along the entire length of 
each chromosome, which reflects the relative copy number of DNA 
sequences in the tumor genome. Disomy or two copies of chromosomes in 
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the two genomes should yield a green-to-red ratio of 1.0 (Kallioniemi et al, 
1992; du Manoir et al, 1993). If the tumor analysed harbors additional 
chromosomal material, like gene amplifications and chromosomal gains, 
hybridization reveals higher ratio of signals intensities at the corresponding 
target regions of the hybridized chromosomes. On the other hand, a lower 
ratio is expected as a result of loss of DNA sequences in the test sample. A 
schematic diagram is illustrated in Figure 2.2 
2.3.2 Applications of CGH 
I) Identification of Hot Spot Genetic Alterations in Cancer 
CGH technique can been applied in cancer genetics, prospectively 
and retrospectively. Hot spots of unbalanced genomic rearrangements can 
been defined by CGH assay on a wide range of tumor specimens, cell lines 
and archival materials. In addition, CGH can reveal novel chromosomal loci 
that involved DNA sequences gain and deletion. For example, a CGH study 
of rhabdomyosarcoma by Steilen-Gimbel et al (1996) revealed a novel site of 
DNA amplification on chromosome 1p32-33. 
II) Analysis of Progression and Clonal Evolution of Cancer 
The genetic changes that accompany the progression from benign 
lesions to malignant lesions with metastasis can also be studied by CGH. 
Currently, classification of histological type of tumor is based on the 
morphological phenotypes. Genetic events associated with tumor 
progression and clonal evolution can be revealed by CGH, and may be 

























































































































































































































































































































Comparative Genomic Hybridization and Fluorescence ln-Situ Hybridization 
(1996) demonstrated some changes (losses on 3p and 9p, and gain on 3q) 
associated with the early development of head and neck squamous cell 
carcinoma in well-differentiated tumors, while a number of additional changes 
in undifferentiated carcinomas indicated progression-associated event. 
III) Association with Clinical Course 
Another strategy is the investigation of tumors associated with a 
distinct clinical course. Specific chromosomal imbalances can be identified 
by CGH analysis in patient groups, namely treated and untreated. For 
example, Cher et al (1996) studied a group of patients with prostate 
carcinoma with metastasis without prior cancer treatment and a second 
group of patients who had developed androgen-independent metastatic 
diseases. They found losses of 8p occurred in a higher frequency in the 
second group. Hence, CGH may be a potential prognostic and diagnostic 
tool in tumor study. 
2.3.3 Advantages and Limitations 
Most molecular techniques provide information on chromosomal 
alterations, however, they target one specific gene or chromosomal region at 
a time leaving the majority of genome unexamined. CGH provides a survey 
of the entire human genome with relative speed and accuracy in assessing 
imbalance chromosomal changes in a single experiment (Kallioniemi et al, 
1992). - In addition, neither prior knowledge of the aberration present nor 
gene-specific probe is required (Tanke et al, 1995). CGH, therefore, is very 
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useful in localization of novel regions that may be indicative of oncogenes 
and tumor suppressor genes involvement. 
Unlike conventional cytogenetics, CGH does not require dividing cells, 
and only requires a few hundred nanograms of DNA materials. CGH assay 
can virtually be applied onto any kind of tumor and tissue type. It is 
especially useful in the analysis of genetic changes underlying solid tumors 
(Houldsworth et al, 1994). Unlike LOH technique, the reference DNA used in 
CGH analysis does not need to come from the blood of the corresponding 
patients. In that sense, the availability of samples and the flexibility in 
investigations can be greatly enhanced. If the amount of DNA material is too 
small, it is also possible to generate sufficient DNA of the whole genome by 
degenerate oligonucleotide primed polymerase chain reaction (DOP-PCR) 
prior to CGH analysis. 
Although CGH is a powerful tool, there are several limitations 
associated with this technique. The ability to identify chromosomal gain or 
loss is dependent on tumour cell content. More than 50% of cells analysed 
must contain the sequence copy number changes. The "contamination" with 
normal cells can result in aberrations being evaded from CGH detection. 
Also, different genetic aberrations in tumor with clonal heterogeneity may not 
be elucidated by CGH (Kallioniemi et al, 1994). 
CGH is limited by the resolution of altered chromosomal regions. 
Overrepresentation of DNA sequences is detectable only if the gained region 
or the amplified unit (amplicon size times the number of copies) exceeds 2 
Mb (Kallioniemi et al, 1994). The sensitivity of CGH for the detection of 
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deletions is even lower, ranged from 10-20 Mb (Kallioniemi et al, 1994; Bentz 
et al, 1995). 
CGH cannot detect balanced translocation, inversions and intragenic 
rearrangement. While it is most efficient in detecting unbalanced 
chromosomal abnormalities, CGH provides no information about how those 
segments involved in gains and losses are arranged structurally in the tumor 
genome. Since CGH only detects DNA sequences copy number changes 
relative to the average copy number in the tumor, identification of ploidy 
changes in tumor is also not applicable (Kallioniemi et al, 1994). 
Last but not the least, CGH analysis depends heavily on the 
availability of specialized instruments. The hardware for image capturing and 
the software for digital image analysis are very expensive. 
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2.4 Method of CGH 
In this study, CGH analysis was applied on frozen NPC tissues, cell 
lines and xenografts and paraffin-embedded biopsies. All chemicals, 
reagents and buffers used are listed at the end of section 2.5. The 
procedures of the experiments were as follow: 
2.4.1 CGH Probe Preparation 
I) DNA Extraction 
a) Tumor Samples for Test DNA 
Frozen Tumors 
Frozen samples were first thawed at room temperature and washed 
with 1x phosphate buffered saline (PBS). They were then minced with sterile 
scalpels and treated with 20 ^ig/ml RNase in 0.5 ml extraction buffer for 1 
hour at room temperature. Five i^l proteinase K (10 mg/ml) was then added 
into the solution and the mixture was allowed to incubate at 55。C for at least 
one day to ensure complete digestion. To the digested mixture, equal 
volume (0.5 ml) of phenol: chloroform: isoamlyalcohol was added and the 
mixture was shaken for 5 minutes at room temperature. It was allowed to 
stand at -20°C for at least 10 minutes prior to centrifugation at 2000g for 30 
minutes (Avanti 30 Centrifuge, Beckman). The upper aqueous layer was 
then collected. The procedures of phenol: chloroform extraction, mixing, 
cooling and centrifuging were repeated for two more times. Finally, DNA in 
the upper aqueous layer collected was precipitated by adding 1/10 volume of 
3 M sodium acetate (pH 5.0) and two times volume of cold absolute ethanol. 
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The mixture was gently inverted up and down until threads of DNA were 
seen. The DNA precipitated was then washed with cold 70% ethanol and 
dried by SpeedVac machine. DNA was then dissolved in 10 to 50 \i\ 
autoclaved filtered double distilled water. The concentration of DNA 
extracted was determined by measuring the absorbance of DNA samples at 
260 nm, 280 nm and 320 nm using UV-VIS spectrometer (Beckman). The 
DNA samples were stored at -20°C. 
Cell Lines 
The procedures were the similar to that of tissue extraction, except no 
mincing was required and prolonged RNase digestion was required. 
Paraffin-embedded Tissues 
Deparaffinization of paraffin-embedded tissues was required prior to 
DNA extraction. This was achieved by treating samples in xylene for 15 
minutes and two times of absolute ethanol for 15 minutes. The dehydrated 
samples were digested in 400 |il STE solution with 0.5% SDS and 0.5 mg/ml 
proteinase K at 55°C overnight. Additional 20 1^ of 10 mg/ml proteinase K 
was added the next day and the samples were further digested for another 3 
to 4 days. After phenol: chloroform: isoamlyalcohol extraction, DNA was 
precipitated by ethanol precipitation as described in the presence of 20 i^l 
glycogen as described in the previous section. 
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b) Normal Blood Samples for Reference DNA 
Twenty to 40 ml normal blood samples obtained were put into 20 ml 
filtered ACD solution overnight at -20°C prior to DNA extraction. Cells were 
lysed in the presence of distilled water and haemoglobin was removed before 
RNase and proteinase K enzymes digestion. DNA was obtained by phenol: 
chloroform method and precipitated by ethanol as described above. 
II) DNA Labeling 
Tumor DNA and reference DNA (46’ XY or 46，XX) were labeled with 
biotin-dUTP and digoxigenin-dUTP, respectively. One ^g DNA was mixed 
with 2.5 |il 10x nick translation buffer, 3 1^ diluted dNTP mix (0.33 mM each), 
1 i^l bio-16-dUTP or dig-11-dUTP (1 mM), 26 units of polymerase, and 3 i^l 
DNA polymerase l/DNase I enzyme mixture, making a final volume of 25 ^l. 
After 1 hour and 45 minutes incubation at 15°C, the reaction was stopped by 
adding 2.5 i^l of0.17 M EDTA. 
The unincoporated dNTPs were removed by NICK Spin Columns 
(Pharmacia Biotech). The columns were washed twice with column buffer 
and were ready for use after centrifugation at 500g for 4 minutes. DNA 
samples were loaded onto the columns and spun at 500g for 4 minutes. 
Purified label-DNA was collected in the wash. The fragment length and the 
labeling efficiency of DNA collected was checked by gel electrophoresis and 
dot-blot respectively. 
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a) Gel Electrophoresis 
The fragment length of nick translation products was resolved in a 1% 
agarose gel, in which 0.2 mg/ml ethidium bromide was included. For each 
sample, 200 ng of labeled DNA was run parallel with 0.5 ^g 1Kb Plus DNA 
Ladder as marker. Prior to loading into the gel, DNA samples and markers 
were mixed with 1x bromophenol blue. After electrophoresis at 130 voltage 
for 20 minutes in 1x TAE buffer, the fragment lengths result could be 
visualized under UV illumination and captured on Polaroid photograph by the 
Polaroid MP4+ instant camera system. The optimum fragment size for CGH 
analysis ranges from 200 to 800 bp. An example of gel electrophoresis of 
nick translation products is shown in Figure 2.3. 
b) Dot-Blot 
Serial dilutions (10 pg/^il, 7.5 pg/^l and 5 pg/^il) of standard 
biotinylated DNA and dig-labeled DNA in DNA dilution buffer were first 
prepared and 1 i^l of each was spotted onto pieces of Hybond^^-N+ nylon 
membrane (Amersham LIFE SCIENCE, UK). The membranes were then 
allowed to dry in an oven at 37°C for at least 1 hour. 
Each sample of labeled DNA, either biotinylated or digoxigeninylated, 
was diluted to 10 pg/^il with TE buffer, of which 1 1^ was blotted onto the 
nylon membrane with correspondent standard DNA. After incubation at 37°C 
for an hour, the membrane was rinsed with maleic acid buffer (pH 7.5). 
Before the addition of antibody solution, the non-specific areas on the 
membrane were blocked with 1x blocking solution for 15 minutes with gentle 
shaking. The membrane was then incubated in anti-biotin or anti-digoxigenin 
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Figure 2.3 Gel electrophoresis of DNA samples after nick translation 
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Lane 1: DNA sample 1 
Lane 2: DNA sample 2 
Lane M: 1 Kb Plus DNA Ladder 
The fragment length of labeled DNA samples ranged from 200 一 
800 bp, which is optimal for CGH assay. 
2- 17 
Comparative Genomic Hybridization and Fluorescence ln-Situ Hybridization 
antibody solution for 15 minutes at room temperature for the detection of 
biotin-labeled or dig-labeled DNA respectively. After three washes with large 
volume of maleic acid buffer and two washes with detection buffer (pH9.5), 
for 5 minutes each, the membrane was allowed to incubate in freshly 
prepared color-substrate solution for about 30 minutes at room temperature 
in the dark. During the color development, no shaking was required. When 
desired spot intensity was achieved, the reaction was stopped by washing 
the membrane with double distilled water. 
To estimate the labeling efficiency of samples, the membrane was first 
scanned by GS-700 imaging densitometer (BioRad). The optical density 
(OD) in the defined area of spots (standard and samples) was measured by 
the Molecular Analyst software (BioRad). The concentration of labeled 
samples and the labeling efficiency were calculated using the three standard 
spots as reference. An example of biotin and digoxigenin dot blot, together 
with the correspondent measurement report and standard curve, is displayed 
in Figure 2.4 and Figure 2.5 respectively. 
III) Probe Mixing and Preannealing 
Labeled DNA samples with suitable fragment length and high labeling 
efficiency were used. Eight hundred ng of biotin-labeled test DNA and 800 
ng digoxigenein-labeled normal DNA (46, XY or 46，XX) was mixed with 56 
|Lig of human Cot-1 DNA, 1/10x volume of 3 M sodium acetate (pH 5.2) and 
2x volume of cold absolute ethanol. The mixture was allowed to stand at 一 
20°C for 1 hour. After centrifugation at 13,000 rpm for 30 minutes at 4°C 
(Avanti 30 Centrifuge, Beckman), a white pellet of DNA was obtained. It was 
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Figure 2.4. An example of biotin dot-blot experiment. 
A) Biotin dot-blot on a Nylon membrane 
The top three spots represent standard biotin-labeled DNA with 10 
pg, 7.5 pg and 5 pg (from left to right). The bottom dots are five 
labeled DNA samples, namely B1 to B5. The color intensity of each 
spot reflects the labeling efficiency of the sample. The closer the 
color intensity of the sample to that of 10 pg standard, the higher is 
the labeling efficiency. 
B) A report for biotin dot-blot by densitometer measurement. 
C) Standard curve for the biotin dot-blot. 
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Name ~~Type““ Area Mean Adjusted Concentration Labelling 
(mm2) OD Volume (pg/^l) efficiency 
(OD X mm2) (%) 
10pg Standard~~3.328""^0.274 0.912 To I 
7.5 pg~~~Standard~~3.328~~0.126 0.422 7^ I 
5 pg Standard~~3.328~~0.108 0.359 5 I 
B1 Unknown~~3.328~~0.176 0.586 7 ^ 72 
B2 Unknown~~3.328~~0.203 0.676 8 ^ ^ 
~ ^ Unknown~~3.328~~0.211 0.702 8 ^ 86 
~ ^ Unknown 3.328~~0.231 0.769 ^ ^ 
~ ^ Unknown~~3.328~~0.215 0.716 8 ^ 89 
C. 
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Figure 2.5. An example of digoxigenin dot-blot experiment. 
A) Digoxigenin dot-blot on a Nylon membrane 
The top three spots represent standard digoxigenin-labeled DNA with 
10 pg, 7.5 pg and 5 pg (from left to right). The bottom dots are two 
labeled DNA samples, namely D1 and D2. The color intensity of 
each spot reflects the labeling efficiency of the sample. The closer 
the color intensity of the sample to that of 10 pg standard, the higher 
is the labeling efficiency. 
B) A report for digoxigenin dot-blot by densitometer 
measuremeAt. 
C) Standard curve for the digoxigenin dot-blot. 
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washed with iced 70% ethanol and dried with SpeedVac machine. It was 
then redissolved in 12 1^ of Hybrisol VII hybridization buffer (50% formamide, 
2x SSC, 10% dextran sulphate). Prior to hybridization, the probe mixture 
was denatured at 75。C for 5 minutes and incubated at 37°C for 45 minutes 
for preannealing. 
a) External Controls 
To access variations between experiments, positive and negative 
external controls were included. A sample with known chromosomal 
aberrations, such as HepG2 cell line, was used as positive control. 
Hybridization of differentially labeled two normal DNA was the negative 
control. 
b) Internal Control 
When tumor and reference DNA from individuals of different sex were 
used, this was refered to as a sex-mismatch experiment. The unbalanced 
sex chromosomes in the probe mixture served as an internal control. 
2.4.2 CGH Template Preparation 
I) Normal metaphase spreads 
A 0.5 ml aliquot of heparinized peripheral blood from a normal male 
was cultured in 5 ml RPMI-1640 medium supplemented with 20% fetal 
bovine serum (v/v), 100 U/ml penicillin and 100 ^g/ml streptomycin, and 1% 
L-glutamine. T-lymphocytes were stimulated to proliferate by 100 1^ of 
phytohemagglutinin (10x). Cell cultures were incubated at 37。C in an 
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atmosphere of 5% carbon dioxide. Settled cells were resuspended once a 
day. After 3 days, metaphases of the dividing cells were arrested by 50 jal of 
25 ^ig/ml colchicine. After incubation at 37。C for an hour, cells were 
collected by centrifugation at 1500 rpm for 5 minutes (MSE Mistral 2000) and 
were treated with 8 ml pre-warmed (37°C) hypotonic solution (75 mM KCI). 
After 1 hour incubation at room temperature, cells were pelleted and the 
supernatant was discarded. The cell pellet was then resuspended with 
freshly prepared fixative of methanol to acetic acid in a ratio of 3:1, which 
was added slowly drop by drop to a final volume of 5 ml. After centrifugation, 
cells collected were resuspended in 5 ml fixative by mild tapping at the 
bottom of the tube and were allowed to stand for 30 minutes at room 
temperature. The supernatant was discarded and another 5 ml fresh fixative 
was added. This procedure was repeated until a clean white pellet was 
observed. After the final fixation step, cell pellet was resuspended in an 
appropriate volume of fixative, depending on cell density. Normal metaphase 
spreads were obtained by dropping aliquots of cell suspension from a 
distance onto cleaned premium superfrost microscopic slides (Fisherfmest, 
FjsherScientific). 
II) Slides Preparation 
a) Slides Pre-treatment 
The slides with normal metaphase spreads were aged at room 
temperature for at least 5 days. They were then treated with 100 ^g/ml 
RNase in 2x SSC (pH 7.0) at 37°C for an hour. After three washes of 2x 
SSC in room temperature, they were dehydrated in a series of ethanol, 70%, 
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80% and 100%, for 2 minutes each. The air-dried slides were incubated in 
30 mg/ml pepsin in 0.01 M HCI solution at 37。C for 3-4 minutes. After pepsin 
digestion, the slides were washed with 2x SSC at 37°C for 4 minutes. Again, 
slides were dehydrated with serial increasing concentration of ethanol (70%’ 
80% and 100%) for 2 minutes each. 
b) Slides Denaturation 
The pre-treated slides were denatured in 70% formamide/2x SSC at 
76°C for one and a half minutes using Hybaid Omni Thermal Cycler for 
slides. They were then dehydrated in cold 70%, 80% and 100% ethanol 
series, for 2 minutes each. After being air-dried, they were ready for 
hybridization. The temperature and duration for slide denaturation varied 
from batch to batch. It aimed to maximize denaturation and probe 
penetration, but without destroying the morphology of chromosomes. 
2.4.3 Hybridization 
The preannealed probe was applied onto the denatured slide and 
covered by a 12x 12 mm coverslip. The edges of coversiip were then sealed 
with rubber cement. The hybridization was carried out in a moist chamber for 
2 days at 37°C. 
2.4.4 Post-hybridization 
After 2 days incubation, rubber cement was pealed and coverslip was 
soaked off in 2x SSC. The slide was then washed twice in 50% 
formamide/2x SSC (pH 7.0) and twice in 2x SSC at 40。C for 5 minutes each. 
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2.4.5 Fluorescence Detection 
Blocking was performed by incubating the slide in freshly prepared 3% 
marvel solution at 37°C for 30 minutes. The slide was then dipped into 4x 
SSC/0.1% Tween 20 solution for 5 minutes at room temperature. All 
antibodies for fluorescence detection were diluted in 1% marvel solution and 
were applied in the following order: 1) avdin-FITC (3: 1000 dilution) and 
monoclonal mouse anti-digoxin (1: 100 dilution); 2) rabbit anti mouse TRITC 
(1: 100 dilution); 3) goat biotinylated anti-avidin D (1: 100 dilution); 4) avdin-
FITC (3: 1000 dilution) and goat anti rabbit TRITC (1: 100 dilution). For steps 
1 and 4，the slide was incubated in a moist chamber at 37°C for 1 hour. For 
steps 2 and 3, incubation for 30 minutes was sufficient. After each 
incubation, the slide was washed with 4x SSC/0.1% Tween 20 solution at 
room temperature for 5 minutes. Chromosomes were counterstained with 0.4 
|Lig/ml DAPI in Vectashield antifading solution to reduce photobleaching. 
2.4.6 Image Acquisition and Analysis 
Hybridized metaphases on slide were captured with a cooled charge 
coupled device camera coupled to a Leitz DM RB (Lecia) fluorescence 
microscope, equipped with a 50 W mercury lamp (Philips). The lamp was 
aligned in the centre so as to achieve the best possible homogeneity of the 
illumination field. Gray level image was acquired sequentially for each 
fluorochrome using an automated filter wheel with three filter sets, for FITC, 
TRITC and DAPI fluorescence signals. All images were taken via 100X /1.3 
oil immersion lens (Lecia). The optimal exposure time was adjusted to obtain 
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high intensity, but saturation value in all pixels was avoided. Exposure times 
and all optical settings of microscope were kept more or less the same for the 
whole series of image acquisition. Eight to ten best metaphases were 
captured from each slide. They were chosen on the basis of the following 
criteria (Kallioniemi et al, 1994; Nacheva et al, 1998): 
1) Hybridization signals on all metaphase spreads were smooth with high 
intensity. 
2) The green and red fluorescence distributions were similar between 
two sister chromatids of a chromosome, and two chromosomal 
homologues in a metaphase, and the same chromosome in different 
metaphases. 
3) Background or non-specific fluorescence level on the slide 
surrounding the chromosome was low. 
4) Metaphase spread with chromosomes showed adequate length and 
minimal overlapping was selected. 
5) DAPI banding should provide sufficient resolution for chromosome 
identification. 
Digital images captured were processed with a CGH software version 
3.1 on an image analyser CytoVision (Applied Imaging, Sunderland, UK). 
Identification of chromosomes was made on the basis of the band pattern 
obtained by reverse DAPI staining. The fluorescence intensity of FITC image 
and TRITC image was calculated, and the ratio profiles along the 
chromosome were generated. By combining the information of ratio from a 
number of metaphases, a statistical average ratio profile and the limits of the 
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95% confidence interval were computed. Chromosomal gains and losses 
were determined if the ratio profile exceeded the threshold value of 1.25 and 
0.75 respectively. Amplifications of DNA sequences were considered when 
the ratios of FITC: TRITC were larger than 1.5. Telomeric regions, as well as 
regions at 1p32-pter, 16p, 19 and 22，were interpreted cautiously. This is 
because convergence on the end of chromosomes give rise to a lower 
fluorescence intensity values that often resulting in unreliable ratio 
calculations, while regions at 1p32-pter, 16p, 19 and 22 have been shown to 
deviate from a fluorescence ratio of 1.0 in normal/normal control 
experiments, (du Manoir et al, 1993; Kallioniemi et al. 1994; Lundsteen et al, 
1995). Also, heterochromatic regions, such as centromeres of chromosomes 
1，9 and 16’ p-arms of acrocentromeric chromosomes, and Yq12, were 
excluded from the CGH analysis, since excess human Cot-1 DNA 
suppresses hybridization in these regions. An example of CGH experiment 
is illustrated in Figure 2.6. 
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Figure 2.6 An example of CGH experiment. 
A) FITC image. DNA from tumor cells was labeled with biotin and detected 
via FITC labeled antibody. 
B) TRITC image. The reference DNA was labeled with digoxigenin and 
detected via TRITC antibody. 
C) DAPI image. The chromosomes were conterstained with DAPI. 
D) Reverse DAPI image. The reverse DAPI staining reveals crude G-
banding pattern for karyotyping. 
E) CGH image. This figure was obtained after combining images captured 
from three different exposures of the same metaphase. 
F) CGH green/ red ratio image. The image was overlaid with pseudocolors 
and displayed the chromosomal imbalance regions in green and red. 
G) Karyotype. Based on the reverse DAPI pattern, the 46 chromosomes in 
the metaphase were identified. 
H) Karyotyped CGH image. Chromosome regions that were 
overrepresented (amplified) in the tumor are visualized in a 
predominantly green, such as 5p. Regions that were lost (deleted) from 
the tumor are seen as regions with predominantly red color, like 4q and 
20p. 
I) CGH profile. The green to red fluorescence intensity ratio profiles are 
shown for all chromosomes alongside the corresponding ideogram. After 
the quantitative digital image analysis on a number of chromosomes 
(n<11), the mean ratio profile (pink line) is obtained and depicted with the 
95% confidence interval (yellow lines). Vertical black line represents 
green to red ratio of 1.0. The first red and green lines next to the black 
line represent thresholds for chromosomal losses (0.75) and gains (1.25) 
respectively. The ratio profiles exceed 1.5 (the second green line) 
indicate the regions of high-level copy gains. The CGH profile suggests 
gains of 1p13-p34.2, 1q21-q43, 2p13-pter, 3p21.2-pter, 3q13.1-qter, 
5q12-q31, 6p22-pter, 6q13-qter, 7, 8q21.3-qter, 9p12-p21, 9q, 11q14-
qter, 12p12-qter, 13，16p, 20q, whereas 3p11-p21.1, 4q, 8p22-q11.2, 
9p22-pter, 10p, 18q, 20p, Xq25-qter and Y were deleted. Chromosomal 
amplifications were also identified on 3q21-q27, 5p, 9q32-qter, Xp22.1-
pter and Xq13. 
L U 
r B 
^ ^ ^ ^ B DAPI Image ^ B ^ M ^ ^ B B ^ ^ ^ f f l 3 | B a ^ B 
mm 








 ^ / ^ , . ^ J
 4 . ^ L f J J ^ ^
 , 1 1 
r ^ s

















 . 1 ^ ;
 - … 
^ ^ ^ i ^ ^ ^ ^ i _ ^ ^ ^ ^ ^ ^ i
 ^
 ^ ^ n ^ n M N ^
 c p r T w w n u
 R B
 _ l = r 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H
 z ^ ^
 i r ^ i ^ n 
I
 2 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H
 ^ ^














^ ^ ^ ^ ^ ^ D H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ I
 n
 - i , . / —
 n ^
 ^ 丨 1 
I ^ I B ^ ^ ^ ^ ^ ^ ^ ^ ^ H
 M M M M n
 roM^ 
^ ^ I M ^ ^ ^ ^ ^ ^ I
 _ S D T n
 _ 5 _ :
 ^ r = 
^ ^ ^ ^ ^ ^ ^ ^ H ^ ^ ^ ^ ^ ^ ^ I
 —
 ：
 D n y Y 
^ ^ ^ H H
 :
 : • 4 
I ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ l ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ l
 J r r . J
 2 
M ^ ^ ^ ^ ^ ^ ^ l
 N U J
 ^
 i n f l ^
 I T I ^ 
m
 l s s ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ l
 u l k h M M V
 》
 J J . r /
 ^ 
14





 a M B H M ^ 4
 1 






 S R M B W
 t r b ^ 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H
 — 
e ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H
 ^
 M M M M M M M M M M M M H
 m ^ F K > ^
 . J r l























 v t t H ^ I ^ H ^ ^ ^ I
 G
 , c > 、
 n
 B 8 3 J .
 ^ ^ ^
 — i
 0 ^ 
^
 ^ ^ ^ I ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ M ^ H
 c
 s n B R R R 0 1 
•
 O ^ ^ ^ ^ ^ I H H ^ ^ H ^ ^ ^ ^ I
 M M M M H U M
 g
 1 ^ 1 
/
K M ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ B H U ^ ^ ^ ^ ^ H ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ H
 i ^
 ^ M M U -
 =
 J y ^ ^ . . - H v . -
 =
 « d f i L 2 
k . 1
 ^ t f ^ ^ ^ ^ ^ ^ ^ ^ H K ^ ^ ^ H ^ ^ ^ ^ ^ ^ H








 H W ^ H f l _ ^ ^ ^ ^ ^ ^ ^ ^ ^ B ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
t l
 2 ^ M S ^ ^ ^ ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ H
 M ^ i
 2
 y H Q y Q y H
 S S H C ^ 
t l I








^ . 1 ^ : 
l i
 n





 i R i ^ ^ ^ ^ ^ ^ ^ ^ ^ H i m ^ ! ^ ^ ^ ^ ^ H I I ^ ^ ^ ^ ^ ^ ^ ^ ^ I
 .
 H M























































^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 9 ^ ^ V ^ ^ ^ H
 " •
 •
 • • _
 = _
 • •








 ^ ^ ^ n ^ ^ ^ m ^ ^ ^ H ^ ^ ^ ^ ^ H
 M
 M M ^ ^ ^
 H n B ^ 
1 I
 I
 ^ ^ ^ M S ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ I
 H H R M H D 7





 ^ ^ ^ ^ ^ ^ V ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H I 11
 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H ^ ^ M ^ ^ H
































l l i ^ ^ l i ^ l i l i ^ l ^ i ^ i ^ ^ ^ i i ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
 ^ H H ^ ^ ^ I ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ I H ^ ^ ^ ^ ^ ^ H H ^ ^ ^ H
 n
 / - , . .
 n
 _ ： n
 -
 n 
l : l i
 •
 i b i u f e 1
 ^ ^ U W B M B h
 - T T W T T I "
 c n a i 2 
d K
 L 
Comparative Genomic Hybridization and Fluorescence ln-Situ Hybridization 
2.5 Method of Interphase FISH 
In this study, interphase FISH cytogenetics was applied on paraffin-
embedded tissue sections. The chemicals and solutions used in this part are 
listed at the end of this section. 
2.5.1 FISH Probe Preparation 
Chromosome-specific a-satellite probes (Oncor) were diluted 20 fold 
with Hybrisol VI hybridization buffer (65% formamide, 2x SSC, 10% dextran 
sulphate). The diluted probes were denatrued at 70°C for 5 minutes and 
then put on ice for 5 minutes before use. For the region specific probes 
(Oncor), neither dilution nor denaturation was required. 
2.5.2 FISH Template Preparation 
Paraffin-embedded tissue sections on glass slides were baked at 65°C 
for 3-5 days. The slides were deparaffinized by incubating in 100% xylene 
overnight and two more times for an hour each. After three washes with 
absolute methanol for 5 minutes each, the slides were air-dried. The slides 
were subsequently treated with 1 M sodium thiocyanate at 80°C for 10 
minutes, followed by two washes in double-distilled water for 5 minutes each. 
Thereafter, the slides were digested with 1 mg/ml pepsin in 0.2 M HCI for 10 
to 15 minutes at 37。C. The enzymatic reaction was stopped by immersing 
the slides in double-distilled water for 5 minutes. This was then followed by 
low-level microwave treatment (600W) for 20 minutes. Pretreated sections 
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were denatured at 80。C for 30 minutes using Hybaid Omni thermal cycler for 
slides and were ready for hybridization. 
2.5.3 Hybridization 
Approximate 10 |^ l per 22x 22 mm area of prepared probe was applied 
onto the denatured sections while they were on the Hybaid Omni slide 
thermal cycler. A coverslip was put on top of the hybridization area and the 
edges were sealed with rubber cement. The slides were then further 
denatured for 10 minutes at 82°C. In-situ hybridization was carried out in a 
moist chamber at 37°C for one to two days. 
2.5.4 Post-hybridization 
Slides were washed in 40% formamide/1.2x SSC (pH 7.0), followed by 
0.5x SSC or 2x SSC solution for 5 to 15 minutes. Hybridization of different 
probes required minor modifications in the washing conditions. 
2.5.5 Fluorescence Detection 
Hybridization signals were detected by two layers of antibody. The 
anitbody solutions were prepared in 1% marvel solution and were applied in 
the following order: 1) 20 ^ig/ml sheep anti-digoxigenin FITC; and 2) rabbit 
anti-sheep lg FITC (1:100 dilution). After 30 minutes incubation of each 
antibody solution, the slides were washed with 4x SSC/ 0.1% Tween-20 
solution at room temperature for 5 to 10 minutes. Nuclei were counterstained 
with 1 ng/ml propidium iodide in VectaShield antifade solution. 
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2.5.6 Scoring of FISH Signals 
Hybridization signals were visualized under the fluorescence 
microscope (Leica DMRB). To minimize bias, double-blinded scoring of 
FISH signals were performed by two independent observers. Both of whom 
had no prior knowledge of clinicopathological information of the patients 
studied. For each case, 300 to 600 nuclei were analyzed and the average 
percentage of cells with signal scores was calculated. Cells were scored 
according the following criteria: 
1 Based on cell morphology. Cells having malignant cytological 
appearance with large hyperchromatic nuclei were scored. Small and 
round lymphocyte-like cells were disregarded. 
2 Overlapping and damaged nuclei were not analysed. 
3 Only bright, punctuated signals were scored as positive. 
4 Two split FISH signals, which were small and close to each other were 
counted as one. 
5 Small, pale, and ambiguous fluorescent deposits in the nuclear area 
were disregarded. 
2.5.7 Threshold Determination 
To determine significant chromosomal copy number increment in the 
tumor samples, a cut-off value was calculated for each probe. FISH signals 
in epithelial layers of cells of normal cases were scored. The population of 
cells that exhibited three or more FISH signals was determined in terms of 
percentage mean. The cut-off value was defined as the value higher than 
the percentage mean plus three standard deviations. 
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List of Chemicals, Solutions and Buffers 
Metaphase chromosomes preparation 
Culture medium for lymphocytes (Gibco BRL, Life Technologies, USA) 
1. 100 ml RPMI-1640 (Gibco BRL, Life Technologies, USA) 
2. 25 ml Fetal Bovine Serum 
3. penicillin/streptomycin (Gibco BRL, Life Technologies, USA) 
(10,000 U/ml and 10 mg/ml respectively) (Gibco BRL, Life Technologies, USA) 
4. 1.3 ml L-glutamine (200 mM) 
Phytohemagglutinin (Gibco BRL, Life Technologies, USA) 
Colchicine (Sigma, St Louis. MO, USA) 
Potassium chloride (Merck, Darmstadt, Germany) 
Methanol (BDH Laboratory Supplies, England) 
Acetic acid (BDH Laboratory Supplies. England) 
20x SSC stock solution (pH 7.0) 
1. 3MNaCI (Sigma, St Louis, MO, USA) 
2. 0.3 M Sodium citrate (Sigma, St Louis. MO, USA) 
RNase solution (Boehringer Mannheim, Germany) 
Absolute ethanol (Merck, Darmstadt, Germany) 
Pepsin (Sigma, St Louis, MO, USA) 
Hydrochloric acid (Riedel-de-Haen, Germany) 
Deionized formamide (Oncor, Gaithersburg, Maryland) 
CGH probe preparation 
1x phosphate buffered saline (Sigma. St Louis. MO, USA) 
100 ml ACD solution 
1. 0.48 g citric acid (Sigma’ St Louis, MO, USA) 
2. 1.32 g sodium citrate (Sigma. St Louis. MO, USA) 
3. 1.47g glucose (Sigma, St Louis, MO, USA) 
Xylene (BDH Laboratory Supplies, England) 
DNA extraction buffer (pH 7.4) 
1. 10 mM Tris-HCI (Sigma. St Louis. MO. USA) 
2. 0.1 M EDTA (pH 8.0) (Sigma, St Louis, MO, USA) 
3. 0.5% SDS (Sigma. St Louis, MO, USA) 
STE solution (pH 7.4) 
1. 0.1 M NaCI (Sigma, St Louis. MO. USA) 
2. 0.05 M Tris-HCI (Sigma. St Louis, MO. USA) 
3. 1 mM EDTA (Sigma. St Louis, MO, USA) 
Phenol:chloroform:isoamlyalcohol (25: 24: 1) (Amresco, Ohio, USA) 
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Proteinase K (Boehringer Mannheim, Germany) 
Glycogen (Sigma, St Louis, MO, USA) 
Sodium acetate (Sigma, St Louis, MO, USA) 
10x Nick translation buffer 
1. 0.5 M Tris-HCI (PH 8.0) 
2. 50 mM MgCI2 
3. 0.5 mg/ml BSA (Sigma, St Louis, MO, USA) 
4. 0.1 M p-Mercaptoethanol (Riedel-de-Haen, Germany) 
dNTP mix (0.33 mM each) 
1. 2 i^l of 100mM dATP (Boehringer Mannheim, Germany) 
2. 2 …of 100mM dCTP (Boehringer Mannheim, Germany) 
3. 2 i^l of 10OmM dGTP (Boehringer Mannheim, Germany) 
4. 594 1^ 1x Nick translation buffer 
Digoxigenin-11 -dUTP (1 mM) (Boehringer Mannheim, Germany) 
Biotin-16-dUTP (1 mM) (Boehringer Mannheim, Germany) 
Polymerase Enzyme (Amersham Life Science, UK) 
DNA polymerase I (0.5 U/^i)/DNAse I (0.4 mU/^l) (Gibco BRL, Life Technologies, USA) 
Column buffer (pH 7.4) 
1. 10mM Tris-HCI 
2. 1 mM EDTA 
3. 0.1%SDS 
50x TAE stock solution (pH 8.0) (1L) 
1. 2 M Tris-base (Sigma, St Louis. MO, USA) 
2. 57.1 ml acetic acid (BDH Laboratory Supplies, England) 
3. 50 M EDTA (Sigma, St Louis. MO, USA) 
1% agarose gel 
1. 0.3 g agarose powder (Biowest, Shanghai, PR China) 
2. 30 ml 1xTAE buffer 
Ethidium bromide (Sigma, St Louis, MO, USA) 
6x bromophenol blue 
1. 0.25% bromophenol blue (Sigma, St Louis, MO, USA) 
2. 0.25% xylene cyanole (Sigma, St Louis, MO, USA) 
3. 30% Glycerol (Sigma, St Louis, MO, USA) 
DNA marker (1 ^g/^l) (Gibco BRL, Life Technologies, USA) 
TE buffer (pH 7.4) 
1. 10mM Tris-HCI 
2. 1 mM EDTA 
Standard biotinylated DNA (Gibco BRL, Life Technologies, USA) 
Standard dig-labeled DNA (Boehringer Mannheim, Germany) 
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DNA dilution buffer (Gibco BRL, Life Technologies, USA) 
Maleic Acid Buffer (pH 7.5) 
1. 0.1 M maleic acid (Sigma, St Louis, MO, USA) 
2. 0.15 M NaCI (Sigma. St Louis, MO. USA) 
10x Blocking stock solution 
1. 10 g Blocking reagent (Boehringer Mannheim, Germany) 
2. 100 ml maleic acid buffer (pH 7.5) 
1x Blocking solution 
1 • 10 ml 10x blocking solution 
2. 90 ml maleic acid buffer (pH 7.5) 
Anti-biotin antibody solution for dot blot 
1 • 2 …anti-biotin-AP Fab fragments (Boehringer Mannheim. Germany) 
2. 10 ml 1x blocking solution 
Anti-Dig antibody solution for dot blot 
1. 1 nl anti-dig-AP conjugate (Boehringer Mannheim. Germany) 
2. 10 ml 1x blocking solution 
Detection buffer (pH 9.5) 
1. 0.1 MTris-HCI 
2. 0.1 M NaCI 
3. 50 mM MgCI2 
Color substrate solution 
1. 33 …NBT solution 丨？^。$卜，^？ ;ec[;no|ogies, USA) 
2. 25 l\ BCIP solution ^^'^^° BRL, L.fe Technologies, USA) 
3. 7.5 ml detection buffer (pH 9.5) 
Human Cot-1 DNA (1 mg/ml) (Gibco BRL, Life Technologies, USA) 
Hybrisol VII Hybridization buffer (pH 7.0) (Oncor. Gaithersburg, Maryland) 
1. 50% formamide 
2. 2x SSC 
3. 10% dextran sulphate 
Post-hvbridization wash and fluorescence detection for CGH 
Deionized formamide (Oncor, Gaithersburg, Maryland) 
4x SSC/0.1% Tween (pH 7.0) 
1. 200 ml 20x SSC stock solution 
2. 1 ml polyoxyethylenesorbitan monlaurate (Tween-20) (Sigma, St Louis, MO, USA) 
3. 800 ml double distilled water 
3% Marvel blocking solution 
1. 0.03 g dried skimmed milk powder (Marvellreland) 
2. 1 ml 4x SSC/0.1 % Tween-20 (pH 7.0) • 
1% Marvel solution 
1. 0.01 g dried skimmed milk powder (Marvel Ireland) 
2. 1 ml 4x SSC/0.1 % Tween-20 (pH 7.0) ’ 
FITC-Avdin DCS (2 mg/ml) 0/ector Laboratories, USA) 
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Goat Biotinylated anti-avidin D (Vector Laboratories, USA) 
Monoclonal mouse anti-digoxin (Sigma, St Louis, MO, USA) 
Rabbit anti-mouse TRITC (Sigma, St Louis, MO, USA) 
Goat anti-rabbit TRITC (Sigma, St Louis, MO, USA) 
DAPI (Sigma. St Louis. MO, USA) 
Vectashield antifading solution (Vector Laboratories, USA) 
Interphase FISH ,_. … .•….…、 ^ (Sigma, St Louis, MO. USA) 
Sodium thiocyanate 
Pepsin (Boehringer Mannheim, Germany) 
Hybrisol VI Hybridization buffer (pH 7.0) (Oncor, Gaithersburg, Maryland) 
1. 65% formamide 
2. 2xSSC 
3. 10% dextran sulphate 
Post-hybridization wash and fluorescence detection for FISH 
Formamide (Merck, Darmstadt, Germany) 
Sheep anti-digoxigenin FITC (Boehringer Mannheim, Germany) 
Rabbit anti-sheep lgG FITC (Sigma. St Louis, MO, USA) 
Propidium iodide (Sigma, St Louis, MO, USA) 
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Chapter 3 FISH Studies on NPC Biopsies Guided by 
CGH Information Derived from Cell Lines and Xenografts 
3.1 Introduction 
The identification of NPC-related chromosomal alterations is believed 
to be the first step towards our understanding of the initiation and progression 
of this cancer. Cytogenetic information on primary NPC is limited. This is 
largely due to the difficulties in culturing tumor cells in vitro. The low mitotic 
index and poor quality of tumor metaphase are also major obstacles in the 
karyotypic analysis. CGH allows a comprehensive analysis of chromosomal 
imbalances in a single experiment without the need of cell culture nor prior 
knowledge of candidate regions involved. CGH is therefore an ideal 
technique towards the study of genetic imbalances in NPC. 
Cell lines and xenografts are invaluable materials for biological and 
functional studies. Not only do they provide endless sources of DNA and 
RNA, but also a more homogeneous population of neoplastic cells. 
Cytogenetic information on NPC, to date, has mostly been derived from cell 
lines and xenografts. However, the karyotypes are often complex and 
presented with many poorly characterized marker chromosomes of uncertain 
origins. Thus, the value of karyotypes obtained has been restricted. Using 
CGH, the origin of those unidentifiable marker chromosomes can be 
assessed. 
Interphase FISH analysis is a useful method to determine 
chromosomal aberrations in solid tumors. Using appropriate probes, 
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numerical aberrations of chromosomes or specific DNA sequences in tumor 
specimens can be examined. Since scoring of FISH signals is based on cell 
morphology, it is particularly useful in the examination of malignant cells in 
the presence of lymphocytes and stromal cells. 
In this part of the study, 17 NPC biopsies, as well as three NPC cell 
lines and three xenografts, have been investigated by CGH. Common DNA 
sequence over- or under-representations identified might highlight sites of 
putative oncogenes and tumor suppressor genes that contributed to the NPC 
carcinogenesis. Consistent chromosomal gains identified have also been 
further investigated by interphase FISH cytogenetics on a series of paraffin-
embedded NPC tissue sections. 
3- 2 
FISH Studies on NPC Biopsies Guided bv CGH Information Derived from Cell Lines and Xenografts 
3.2 Materials and Methods 
3.2.1 CGH Analysis 
I) Materials 
a) Tumor samples 
NPC Biopsies 
Biopsies were taken from 17 patients at first diagnosis at the Prince of 
Wales Hospital. Each sample taken was snap frozen in OCT embedding 
medium (Tissue-Tak, Elkhart, IN) and stored at ~80°C until analysis. 
NPC Cell lines and Xenografts 
Three NPC cell lines (CNE-1, CNE-2 and HK-1) and three xenografts 
(Xeno-666, Xeno-1915, and Xeno-2117) were studied. These samples were 
kindly provided by Professor Dolly Huang, Department of Anatomical and 
Cellular Pathology, The Chinese University of Hong Kong. 
HK-1 and CNE-1 were established from well-differentiated NPC, while 
CNE-2 was from a poorly differentiated carcinoma. All three cell lines were 
negative for the presence of EBV DNA, although CNE-2 was reported to be 
EBV positive in the early passages. 
NPC xenografts, Xeno-666, Xeno-2117 and Xeno-1915, were 
established through serial passages of biopsies of NPC tissue in athymic 
nude mice (BALB/c, nu/nu). All three xenografts were derived from 
undifferentiated NPC and showed the presence of EBV DNA with expression 
of EBV nuclear antigen. 
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Controls 
A hepatocelluar carcinoma cell line, with known chromosomal 
imbalances, was used as a positive control HepG2 (Simon et al, 1982). For 
negative control, normal blood samples (XY, 46 or XX, 46) were used. 
b) Normal Blood Samples 
Peripheral blood samples of normal individuals were kindly donated by 
the laboratory staff of the Sir Y.K. Pao Centre for Cancer, Prince of Wales 
Hospital. A portion of samples collected was cultured for normal metaphase 
as CGH template, and the rest extracted for reference DNA. 
II) Method of CGH 
The detail procedure of CGH analysis carried out was as according to 
method described in Section 2.4. 
3.2.2 Interphase FISH Analysis 
I) Materials 
a) NPC Biopsies 
Formalin-fixed paraffin-embedded NPC biopsies (NP1-NP37) from 37 
patients were provided by Professor K.F. To, Department of Anatomical and 
Cellular Pathology, The Chinese University of Hong Kong. Consecutive 
tissue sections of these biopsies were used in order to account for the ploidy 
status of samples studied. 
All 37 NPC patients were ethnic southern Chinese, 32 males and 5 
females, aged 24 to 79 years old. Thirty-three cases were from patients 
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diagnosed with NPC for the first time, while the remainder was local 
recurrence cases. Of the 33 first diagnosed cases, 4 were classified as 
stage II, 3 as stage III and 26 as stage IV according to the Union International 
Contre le Cancer (UICC) staging classification scheme (1987). In this study, 
stages l-lll were categorized as 'early stage’ (19%), while stage IV and local 
recurrence (81%) were regarded as 'advanced stage，. The histological 
features of all NPC sections were diagnosed as either poorly differentiated or 
undifferentiated carcinoma. A hematoxylin-and-eosin (H&E) stained section 
of one of these cases is shown in Figure 3.1B. 
b) Normal Nasopharyngeal Epithelial Tissues 
Four normal nasopharyngeal epithelium tissues with no evidence of 
malignancy were also provided. They were used to establish the cut-off 
threshold for the presence of significant trisomy population of a particular 
probe in the tumor samples. The cut-off value was determined as 
percentage mean plus three standard derivations of cells scored with three or 
more signlas per nucleus. An H&E stained section of a normal case is 
shown in Figure 3.1A. 
c) Probes 
Commercially available chromosome-specific a-satellite probes, 7 
(D7Z1) and 8 (D8Z2), as well as a region specific probe of c-myc (8q24) 
probe (Oncor, Gaithersburg, Maryland), were selected on the basis of CGH 
findings. All probes were digoxigenin-labeled. Chromosome-specific a-
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Figure 3.1. H&E Staining of Nasopharynx Tissue Sections (X200). 
A. Normal epithelial tissue (case 95S5410). The epithelial cells 
exhibited ciliated pseudostratified columnar type. B. Undifferentiated typ  of nasopharyngeal carcinoma (case NP5). Nucleui are vesicular with a sing  prominent eosinophoilicn l olus. The t m r cells are infiltrated by darkly stainedlympocytes. 
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dextran sulphate as described in Section 2.5. The specificity of these probes 
was tested on normal metaphase spreads prior to the application onto tissue 
sections (Figure 3.2). 
II) Method 
Interphase FISH analysis was carried out as mentioned in Section 2.5, 
with minor modifications as follows : 
a) Hybridization 
In situ hybridization of a-satellite probes was performed overnight, 
while hybridization of c-myc was prolonged for one more day. 
b) Post-hybridization 
Tissue sections hybridized with a-satellites 7 and 8 were washed in 
40% formamide/1.2x SSC (pH 7.0) and then in 0.5x SSC, at 42。C for 15 
minutes each. For c-myc probe, sections were washed with 40% 
formamide/1.2x SSC (pH 7.0) at 42。C for 10 minutes, followed by 2x SSC at 
room temperature for 5 minutes. 
3.2.3 Statistical Analysis 
The correlation of clinical staging of patients (early and advanced) with 
FISH findings of a-satellite 7 and 8, c-myc copy number gains was assessed 
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3.3 Results 
3.3.1 CGH 
I) NPC Frozen Tissues 
CGH findings on 17 NPC frozen biopsies are shown on Table 3.1. No 
apparent abnormalities were detected in all samples. CGH profiles of two 
examples, cases CU12 and CU15, are illustrated in Figure 3.3A-B. 
II) NPC Cell Lines and Xenografts 
CGH studies on 3 NPC cell lines and xenografts (Figure 3.3C-H) 
revealed a complex pattern of copy number gains and losses (Table 3.2). 
Consistent gains of 7p and 8q were found in all xenografts and cell lines 
studied. The minimal overlapping regions were 7p15-cen and 8q21.1-q22 
(Figure 3.4). Other common gains included 1q (1/3 xenografts; 2/3 cell lines), 
3q (2/3 xenografts; 2/3 cell lines), 9q (2/3 xenografts; 3/3 cell lines), 12q (2/3 
xenografts; 3/3 cell lines) and 20q (1/3 xenografts; 3/3 cell lines). Frequent 
losses were identified on 3p (2/3 xenografts; 3/3 cell lines), 11q (3/3 
xenografts; 1/3 cell lines), 18q (1/3 xenografts; 3/3 cell lines) and Xq (2/3 
xenografts; 2/3 cell lines). The common overlapping regions were narrowed 
down to 3p21.1-cen, 11q14-qter, 18q21-qter and Xq27-qter respectively. 
III) Positive and Negative Controls 
Chromosomal aberrations detected in the positive control, HepG2 cell 
line, were consistent in all CGH experiments (Figure 3.5A). No chromosomal 
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changes were detected in the negative control experiment (Figure 3.5B), 
which is the hybridization of differentially labeled normal DNA against each 
other. 
3.3.2 Interphase FISH Analysis 
I) Control Samples and Cut-off Values Determination 
The cut-off values of three probes were determined from signals 
scored on epithelial cells of four normal nasal epithelial tissues. The average 
signal percentages of scored cells in each control case is presented in Table 
3.3A-C. The cut-off values for the presence of three or more a-satellite 
probes 7 and 8 signals were determined as 12.10% and 11.34% respectively. 
Threshold for significant polysomy c-myc signals in cell population was 
determined to be 8.19%. Examples of disomy signals of these probes on 
normal nasopharyngeal tissue sections are displayed in Figure 3.6. 
II) Paraffin-embedded Tissue Sections of NPC 
FISH signals scored of a-satellites 7 and 8, and c-myc on the 37 NPC 
biopsies are tabulated in Table 3.4. The presence of significant trisomy 7 and 
trisomy 8 was identified in 10 cases (27%) and 16 cases (43%) respectively. 
Increased in c-myc copy number was identified in 22/37 cases (60%). Of 
particular interest, c-myc signal clustering was observed in one case (NP30). 
Of these 22 cases, seven cases (NP1, NP3, NP4, NP12, NP20, NP26 and 
NP36) showed c-myc copy increment without significant a-satellite 8 signals 
gain. In 15 cases that showed both a-satellite 8 and c-myc copy number 
increment, six cases (NP2, NP14, NP17, NP24, NP33 and NP37) were 
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presented with a higher relative percentage of significant a-satellite 8 to c-
myc signals. Pictures showing three or more FISH signals per nucleus in 
these NPC biopsies are displayed in Figure 3.7. 
3.3.3 Statistical Analysis 
No significant correlation was found (p > 0.05) between increment in 
FISH signals and clinical stages of NPC patients studied (Table 3.5). 
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Table 3.1 CGH findings of 17 NPC frozen biopsy samples 
Case Sample ID Sexy'Age CGH findings 
1 CU4 i ^ Normal 
2 CU5 M/63 Normal 
3 CU7 M/59 Normal 
4 CU8 M/67 Normal 
5 CU10 M/49 Normal 
6 CU11 F/49 Normal 
7 CU12 M/40 Normal 
8 CU13 M/47 Normal 
9 CU14 M/32 Normal 
10 CU15 F/59 Normal 
11 CU17 M/59 Normal 
12 CU19 M/69 Normal 
13 CU20 M/74 Normal 
14 CU21 M/41 Normal 
15 CU23 F/54 Normal 
16 CU24 M/38 Normal 
17 CU25 M/41 Normal 
3 - 12 
Figure 3.3. CGH profiles of two NPC biopsies, three cell lines and three 
xenografts. The mean ratio profile (pink line) is obtained after digital imaging 
analysis and depicted with 95% confidence interval (yellow lines). Eight to 12 
metaphases were analysed in each cases. Vertical black line represents 
green to red ratio of 1.0. The first red and green lines next to the black line 
represent thresholds for chromosomal losses (0.75) and gains (1.25), 
respectively. The ratio profiles exceed 1.5 (the second green line) indicate 
the regions of high-level copy gains. 
A) CU12. Normal profile is shown. 
B) CU15. No aberration was detected. 
C) CNE-1. 
Losses:3p21-q12, 10p, 18, Xp21-qter. 
Gains: 1q, 3q13.1-qter, 5p13-pter, 6p21.3-pter. 6q22-q26, 7p15-pter, 8q21.1-q24.1, 9q31-
qter, 11p, 12q21-qter, 16p13.2-q22, 20q. 
Amplifications: 3q25-q27, 9q33-qter. 
D) CNE-2. 
Losses:3p21-q12, 4p12-qter, 9p22-pter, 10p, 18. 20p, Xq27-qter, Y 
Gains: 1p13-p34.3, 1q21-q43, 2p13-pter, 3p21-pter, 3q13.1-qter, 5q12-q31,6p21.3-pter, 
6q13-q26, 7, 8q,9p13-p21, 9q, 11q14-q23, 12q12-q24.1. 13, 16p, 17q12-qter, 20q, 22q12-
qter, Xpter-q25 
Amplifications: 5p, 8q23-24, 9q32-qter. 
E) HK-1. 
Losses: 3p, 4p11-p15.3, 5p11-p14, 5q14-q31, 6p, 8p, 10p12-pter, 11q14-qter, 13q14-qter, 
18q,Xp, Y. 
Gains: 7p15-q21. 8q, 9p13-qter, 12p, 12q22-qter, 14. 16, 17p, 20q, Xq24-qter. 
Amplifications: 9q33-qter 
F) Xeno-666. 
Losses: 6pter-q13, 11q14-qter, 14q24-qter, 16q, 18q21-qter 
Gains:7, 8, 9, 12q23-qter. 
G) Xeno-1915. 
Losses: 3p, 5pter-q12, 9p, 11q, 14, X 
Gains: 3q13.1-qter, 6q, 10q, 12p11.2-q24.1, 15, 18 
Amplifications: 2p, 7, 8 
H) Xeno-2117. 
Losses: 3p12-p24, 5q, 6, 9p, 11p, 11q14-qter, 13, Xq21-qter. 
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Figure 3.5 CGH profiles of positive control (HepG2) and negative control. 
A) HepG2 cell line was used as the positive control. 
Gains: 2，6p, 6q22-q26, 7, 17q21-q24, 20 、 
B) Negative control was the co-hybridization of differentially labelled DNA 
from two healthy male individuals. No aberration is shown. 
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Table 3.3 Determination of cut-off values of a-satellite 
probes 7 and 8, and c-mvc from four normal nasopharynx tissues 
A. ~ " " ^ ~ " " " ' ^ ^ ~ Probe satellite 7 
Case FISH Signals per Nucleus (%) 
NP normal 0 1 2 3 or more 
95S5410 I m l330 7050 4 M 
95S6803 1.50 21.75 70.50 6.25 
95S7029 1.00 21.50 71.00 6.50 
95S5892 2.50 17.50 79.00 1.00 
Mean 1.75 21.06 72.75 4.44 
S.D. 0.65 2.54 4.17 2.55 
Mean+3S.D. 3.69 28.67 85.27 12.10 
Cut-offValue: 12.10 
B. ' • Probe satellite 8 
Case FISH Signals per Nucleus (%) 
NP normal 0 1 2 3 or mbre 
95S5410 ^ 27；^ 69；^ 0 ? ^ 
95S6803 2.25 29.75 64.25 3.75 
95S7029 4.10 21.30 68.50 6.10 
95S5892 2.50 25.25 67.00 5.25 
Mean 2.84 25.95 67.25 3.96 
S.D. 0.85 3.60 2.21 2.46 
Mean+3S.D. 5.39 36.76 73.87 11.34 
Cut-offValue: 11.34 
C. c-myc Probe (8q24) _ 
Case FISH Signals per Nucleus (。/。) 
NP normal 0 1 2 3 or more 
95S5410 Z l 5 20?^ 7 ^ s M 
95S6803 2.75 19.75 75.00 2.50 
95S7029 2.50 31.75 64.00 1.75 
95S5892 3.50 22.25 71.75 2.50 
Mean 2.75 23.63 70.69 2.94 
S.D. 0.54 5.51 4.70 1.75 
Mean+3S.D. 4.37 40.16 84.78 8.19 
Cut-off Value: 8.19 
3- 20 
Figure 3.6 Disomy FISH signals (a-satellites 7’ 8 and c-myc) on normal 
nasopharynx tissue sections (X750). The nuclei were counterstained with PI, 
and the probes were tagged with FITC. 
A) a-satellite 7 probe, (case 95S5818) 
B) a-sateilite8 signals in case 95S7029. 
C) Two copies of c-myc per nucleus in case 95S5410. 
• • • 
Table 3.4 Interphase FISH analysis using a-satellite probes 7 and 8，and 
c-myc on 37 NPC biopsies. 
• Cases showing the percentage of three.or more FISH signals per nucleus 
exceeded the cut-off values are highlighted. Out of 37 cases, significant 
copy number gains of a-satellite probes 7 and 8, and c-myc were found in 
10, 16and 22 cases. 
• The hybridization efficiency of FISH experiment was reflected from the 
percentage of cells that contained no signals. Almost all cases with zero 
FISH signals for each probe were below 10%, indicating the hybridization 
efficiency reached over 90%. 
• LR: local recurrence 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.7 Interphase FISH analysis using a-satellites 7 and 8, and c-myc 
on paraffin-embedded NPC biopsies (X750). The nuclei were counterstained 
with PI, and the probes were tagged by FITC. 
A) Trisomy signals of a-satellite 7 in a population of cells in case NP9. 
B) A nucleus displays four signals of a-satellite 7 in case NP30. 
C) Three copies of a-satellite 8 in case NP33. 
D) Cells showing copy number increase of a-satellite 8. (case NP17) 
E) Three or four signals of a-satellite 8 per nucleus is shown (case NP5). 
F) Of the same case (NP5) in E, copy number increment of c-myc was 
observed. 
G) Three copies of c-myc per nucleus in case NP6. 
H) More than three copies of c-myc are displayed in case NP17. 
I) Clustering of c-myc signals was observed, (case NP30). 
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Table 3.5 Correlation of copy number increment of FISH signals (a-
satellite 7, a-satellite 8 and c-myc) in 37 NPC patients with their clinical 
stages bv Fisher exact test (2-tailed) 
Numerical Early stage] Advanced Stage^ p-value 
aberrant 
g-satellite 7 ~ 1/7 9/30 0.647 
a-satellite 8 ~ ~ 5/7 11/30 0-202 
— c-myc 5/7 17/30 0.677 
1: UICC stages l-lll were categorized as early stage 
2: Advanced stage included stage IV and local recurrence 
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3.4 Discussion 
3.4.1 CGH 
I) Negative CGH Findings from 17 NPC Frozen Biopsies 
CGH analysis on 17 NPC biopsies detected no apparent chromosomal 
aberrations. Since the reliability and sensitivity of CGH analysis are strictly 
dependent on the homogeneity of the extracted tumor DNA, the admixture of 
non-tumorous cells would therefore "dilute" the overall copy number changes 
(Kallioniemi et al, 1994). The infiltration of large amount of normal 
lymphocytes is a common phenomenon in NPC, and together with the 
presence of other non-tumor cells, like stromal cells and fibroblasts, are likely 
to have hampered the present CGH analysis. 
II) CGH Findings from NPC Cell Lines and Xenografts 
NPC cell lines and xenografts contain "pure" tumor cells that are 
invaluable starting material for genetic studies. Three NPC cell lines and 
three NPC xenografts have been analysed by CGH. Of these, two cell lines 
(CNE-1 and CNE-2) and two xenografts (Xeno-2117 and Xeno-1915) have 
been previously karyotyped by conventional G-banding analysis (Zhang et al, 
1982 & 1983; Huang et al, 1989). Karyotyping on Cell-666, which was 
derived from Xeno-666, has also been reported (Hui et al, 1998). The 
chromosome modal number of cell lines and xenografts ranged from 
hypodiploid in Cell-666 to hypertetraploid in CNE-2, and contained extensive 
chromosomal rearrangements. The CGH findings found were compared with 
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a) CNE-1 
CNE-1 cell line has shown to have hypotriploid karyotype and several 
marker chromosomes. Translocations and isochromosomes were also 
observed. Additional DNA materials from chromosomes 1, 3, 5, 8，12 and 20 
identified by CGH could be indicative of the marker chromosomes and 
isochromosomes found being derived from these imbalances. 
b) CNE-2 
CNE-2 cell line contains 103-104 chromosomes with more than twenty 
marker chromosomes of uncertain origins identified. CGH revealed genetic 
aberrations on almost all chromosomes. Gains on chromosomes, such as 8q 
and 13q, supported the G-banding analysis, which suggested 
isochromosomes of8q and 13q. 
c) Xeno-666 
A complex karyotype of Cell-666 was reported, which may represent 
the cytogenetic information of Xeno-666. CGH results identified are 
consistent with findings of chromosome 9 gain and deletions of 
chromosomes 11, 14 and 18 by banding technique. However, deleted Xq 
and loss of 21 as interpreted by banding analysis were not detected in the 
present CGH study. 
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d) Xeno-1915 
Xeno-1915 is hypotriploid in chromosome number and has marker 
chromosomes of poorly characterized origin. CGH revealed 
overrepresentations of chromosomes 7，8, 15 and 18, which were also 
described in the karyotype. Some aberrations, such as losses of 3p, 9p, 11q 
and 14, identified by CGH were not observed in the banding analysis. 
e) Xeno-2117 
The cytogenetic analysis of Xeno-2117 has revealed hypotetraploid 
karyotype with a homogeneously stained region (HSR) chromosome. Extra 
copies of chromosomes 2’ 7，15 and 18 revealed by karyotyping were also 
detected by CGH. 
In this series of NPC cell lines and xenografts, chromosomal gains 
and losses identified by CGH agreed with the reported karyotypes to certain 
extent. In some instances, the results presented by CGH and conventional 
cytogenetics were discrepant. The disagreement could be due to the 
incomplete description of complex karyotype in NPC cell lines and 
xenografts. Although CGH is unable to detect balanced genetic 
rearrangements, such as translocations and inversions, and ploidy changes, 
an overall genetic imbalances in the genome can be elucidated in relative 
speed. In acute myeloid leukaemias. CGH findings and chromosome 
banding results exhibited a good correlation in such a way that all 
chromosomal imbalances detected by CGH could be confirmed by G-
banding analysis (Bentz et al, 1995). 
3- 30 
FISH Studies on NPC Biopsies Guided bv CGH Information Derived from Cell Lines and Xenografts 
Although additional genetic changes might have been accumulated 
with prolonged in vitro culture, recurrent abnormalities identified in the 
present series of NPC cell lines and xenografts might reflect those changes 
being present in the primary tumour and carried through clonal evolution. 
Consistent gains were identified on chromosomes 7, 8 and 12q, and frequent 
losses were found on 3p, 11q, 18q, and Xq. A previous CGH study on the 
comparison of oral squamous cell carcinomas and the corresponding cell 
lines derived demonstrated a similar pattern of genomic imbalances in three 
out of four cases (Komiyama et al, 1997). This finding suggests copy 
number changes in the primary tumor are mostly maintained in the ceil lines 
derived. 
3.4.2 Interphase FISH Analysis 
To examine whether chromosomal gains of 7 and 8 are present in 
NPC or not, interphase FISH cytogenetics was performed on a large series of 
archival paraffin-embedded NPC tissue sections. Since scoring of FISH 
signals is based on cell morphology, interphase FISH enables cell-to-cell 
analysis of genetic alterations of particular chromosome or DNA sequences. 
In the case of NPC, malignant epithelium can be easily distinguished from 
the infiltrated lymphocytes and the surrounding stromal materials. Two 
enumeration probes, a-satellites 7and 8, were studied. The possible 
involvement of candidate oncogene c-myc mapping on 8q24, was also 
investigated. 
In this part of the study, interphase FISH analysis on NPC biopsies 
confirmed and revealed the occurrence of a-satellite 7 and a-satellite 8, and 
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C-myc overrepresentations in NPC. These aberrations are discussed as 
follow: 
I) Gain of Chromosome 7 
FISH analysis detected trisomy 7 in 27% of NPC cases. Gain of 
chromosome 7 has frequently been reported in follicular lymphomas (Avet-
Loiseau et al, 1997)，glioblastoma (ScNegel et al, 1996), and renal adenoma 
(Kovacs et al, 1991). Candidate protooncogenes on chromosome 7 include 
EGFR (7p12), which encodes for epidermal growth factor receptor, and MET 
(7q31), which encodes for hepatocyte growth factor/scatter factor receptor. 
Amplification of EGFR and MET genes has been described in glioblastoma 
(Schlegel et al, 1996) and gastric carcinoma (Seruca et al, 1995) 
respectively. The molecular consequences of chromosome 7 increment in 
NPC are however unknown. 
II) Gain of Chromosome 8 
Significant increase of a-satellite 8 FISH signals was found in 43% of 
NPC cases studied. The incidence of gain of chromosome 8 was much 
higher than that of chromosome 7, indicating a more important role of 
chromosome 8 gain in NPC development. 
Previous CGH studies suggested gain of chromosome 8 is common in 
tumors, including acute lymphoid leukemia (Larramendy et al, 1998), prostate 
carcinoma (Takahashi et al, 1996; Nupponen et al, 1998), astrocytic tumor 
(Schr6ck et al, 1996), and hepatocelluar carcinoma (Wong et al, 1999). Of 
these, the q-arm is very often affected. From the CGH findings of NPC cell 
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lines and xenografts, overrepresentation of 8q has also been frequently 
detected. 
III) Gain of c-myc 
Interphase FISH analysis revealed three or more copies of c-myc were 
significantly present in 22 out of 37 NPC cases (60%). Most cases showed 
low level copy number gain of c-myc (Figure 3.7F-H), except case NP30, 
which presented clustering signals of c-myc (Figure 3.71). Gain of extra 
copies of c-myc might be passive to chromosome 8 copy number gain. 
However, since seven out of the 22 cases showed significant c-myc 
population in the absence of a-satellite 8 involvement. This suggests c-myc 
gain can occur as an independent event to whole chromosome 8 gain. In 15 
cases, both a-satellite 8 and c-myc FISH were significantly increased, 
suggesting simple gain of 8 account for the additional copies of c-myc gene. 
From a previous study, overexpression of c-myc has been detected in 
90% of patients with NPC (Porter et al, 1994). However, the genomic 
alteration of this gene in NPC has not been recognized. This present 
findings confirmed c-myc copy number increment at the genomic level and 
probably represent the underlying mechanism in the activation and 
overexpression of c-myc in NPC. 
The protooncogene c-myc has been initial discovered as the cellular 
homologue of v-myc, the transforming gene from the avian myelocytomatosis 
virus MC29. c-myc gene containing about 6-7 kbp encodes a nuclear 
protein, p62. Its role is implicated in control of cell proliferation (Makino et al, 
1984), cell differentiation (Cole et al, 1986) and apoptosis (Studzinski et al, 
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1986). High level of c-myc expression reflects the proliferating status in a cell 
and facilitates the transition from GO to G1 phases in the cell cycle 
(Kaczmarek et al, 1985). During cell differentiation, c-myc level decreases. 
In the absence of nutrient, c-myc may accelerate programmed cell death. 
Previous studies have demonstrated expression of c-myc in mammary tissue 
in transgenic mice can cause carcinoma development (Schoenenberger et al, 
1988). Oncoprotein c-myc may interact with a number of transcriptional 
regulatory proteins and form heterodimer complexes. These regulatory 
proteins include MAX, MAD and MXI. MYC-MAX heterdimers can cause a 
change in the conformation of DNA, while MAD-MAX and MXI-MAX dimers 
have opposite effect. The level of transcription from c-myc target genes is 
likely dependent on the relative amounts of different heterodimers formed 
within the cells (Davis et al, 1993). 
Based on current knowledge regarding the cellular functions of c-myc, 
it might explain the deregulation of c-myc production in cells can have potent 
effects in neoplasic transformation. Amplification of c-myc has been 
observed in many human neoplasms, such as hepatocelluar carcinoma 
(Peng et al, 1993), gastric carcinoma (Suzuki et al, 1997), ovarian carcinoma 
(Sasano et al, 1990), and endometrial carcinoma (Monk et al, 1994). The 
excess c-myc might have adverse effect on tumor behavior and progression 
as well. Amplification of c-myc has been demonstrated to be correlated with 
a shorter cancer free interval and the overall survival in patients with breast 
carcinoma (Borg et al, 1992). Moreover, overexpression of c-myc has also 
been suggested to be correlated poor prognosis in NPC (Porter et al, 1994). 
In the present study, however, no significant relationship between c-myc 
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gene copy increment and the clinical staging in NPC has been found. This 
might due to most of the NPC cases (over 80%) being advanced stages, 
therefore making a comparison difficult. 
In six cases with both a-satellite 8 and c-myc increment, a relative 
lower percentage of c-myc were presented. Also, one case (NP23) showed 
significant trisomy 8 without the accompany of c-myc copy number 
increment. These observations, together with the minimal overlapping region 
8q21.1-q22 identified from CGH analysis of NPC cell lines and xenografts, 
suggest that other gene(s), besides c-myc, residing on the proximal region of 
8q, is also involved in the NPC carcinogenesis. A replicating region on 8q 
independent of c-myc, has been suggested in breast carcinoma (Fejzo et al, 
1998), bladder carcinoma (Bruch et al, 1998) and osteosarcoma (Tarkkanen 
et al, 1995). Further investigations are required to evaluate the possible 
presence of NPC-related gene(s) in this region. 
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3.5 Summary of This Chapter 
The extensive infiltration of normal lymphocytes in NPC tissue is likely 
to have hampered the present CGH analysis on the biopsies. Tissue 
microdissection may help to resolve this problem. NPC cell lines and 
xenografts have provided invaluable information on the chromosomal 
imbalances. Consistent gains of chromosomes 7 and 8 were found by CGH. 
Subsequent interphase FISH cytogenetics on paraffin-embedded sections of 
NPC biopsies revealed the incidence of chromosome 8 (a-satellite 8 and c-
myc) increment was much higher than that of chromosome 7. It is possible 
that gain of 7 has conferred growth advantage in NPC cells in vitro and 
chromosome 8 played an important role in cell transformation. The 
increment of c-myc identified in this series of NPC biopsies might suggest a 
dysregulated function of c-myc in NPC by disrupting the normal cell-cycle 
machinery. However, the possible involvement of other oncogene(s) on 
proximal 8q in the NPC tumorigenesis cannot be ruled out. 
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Chapter 4 CGH Studies on Universally Amplified DNA from 
Microdissected NPC Biopsies and Interphase FISH Analysis 
4.1 Introduction 
To reduce the "dilution" effect of normal cell contamination in NPC 
biopsies, tissue microdissection for malignant epithelial colonies was 
attempted in this study. Under the microscope, tumor colonies showing 
malignant morphology were isolated from the admixed cell populations. 
However, the small amount of DNA recovered rendered it insufficient material 
for CGH analysis. Universal genome amplification using degenerate 
oligonucleotide primed-polymerase chain reaction (DOP-PCR) was, 
therefore, carried out prior to CGH analysis. 
DOP-PCR, developed by Telenius in 1992, allows hundreds-fold of 
whole genome amplification of human DNA for genetic analysis. DOP primer 
(5'-CCGACTCGAGNNNNNNATGTGG-3') contains a central cassette of 
random hexamer sequence and is flanked by defined sequences at the 5, 
end (10 nucleotides) and 3, end (6 nucleotides). The amplification procedure 
is divided into two parts: 1) low stringency (5 cylces) and 2) high stringency 
(35 cycles). In the first part, PCR is performed at a low annealing 
temperature (Ta=30°C), which allows a frequent annealing of DOP primers at 
many different sites of DNA template. The Taq DNA polymerase works in 
the 5’ to 3’ direction and extends a new strand of DNA sequences at primed 
regions. After 5 cycles, a pool of different DNA sequences, which represents 
a statistically distributed subpopulation of the entire genome, is generated. 
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The low stringent PCR cycles are followed by a more stringent condition with 
a higher annealing temperature (Ta=62°C). It allows specific base pairing of 
the full length primer sequences to the DNA fragments that have been 
synthesized in the first step. Therefore, after 35 cycles of specific priming 
and amplification, the pre-amplified DNA sequences produced, which 
represent the entire genome, are exponentially increased in amount. A 
schematic diagram of DOP-PCR is illustrated in Figure 4.1. 
In this part of study, the combination of DOP-PCR and CGH has been 
applied on 11 manually microdissected NPC tumors, 10 paraffin-embedded 
tissues and one frozen biopsy. Non-random chromosomal 
overrepresentations on 11q13 has been identified. To further investigate the 
involvement of chromosome 11 and candidate oncogene, lnt-2, in the NPC 
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4.2 Materials and Methods 
4.2.1 CGH on Universally Amplified DNA 
I) Materials 
a) NPC Patients 
Ten paraffin embedded NPC biopsies (NP0-NP9) and one frozen NPC 
tissue (CU19) were manually microdissected by staff of Department of 
Anatomical and Cellular Pathology, The Chinese University of Hong Kong. 
b) Controls and Reference DNA 
An NPC cell line, CNE-2', was used as a positive control. Genomic 
DNA from normal individuals (XY, 46 or XX, 46) was used as negative control 
and the reference DNA in CGH experiments (see Section 2.4). 
II) Methods 
a) DOP-PCR 
Genomic DNA was extracted from the microdissected NPC cells as 
described in Section 2.4. DOP-PCR was performed on a PTC200 Peltier 
thermal cyder (MJ research) using 10 ng genomic DNA as template. Each 
PCR reaction contained 1.7 1^ of 100 ^M DOP-PCR primer [5'-
CCGACTCGAGNNNNNNATGTGG-3'] (Genset, Japan), 10 i^l o f2mM dNTP 
(Boehringer Mannheim, Germany), 10 1^ of 10x PCR buffer II [100 mM Tris-
HCI (pH 8.3) and 500 mM KCI] (Perkin-Bmer’ USA), 8 i^l of 25 mM MgCI2 
(Perkin-Elmer, USA) and 5 units NativeTaq DNA polymerase (Perkin-Elmer, 
USA), making up to a final volume of 100 |il. Amplification was carried out by 
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an initial denaturation for 10 minutes at 93°C, followed by five cycles of 1 
minute at 94°C, 1.5 minutes at 30°C, 3 minutes for transition from 30 to 70°C 
and 3 minutes extension at 72°C, then followed by 30 cycles of 1 minutes at 
94°C, 1 minutes at 62°C and 3 minutes at 72°C, with an addition of 1 
sec/cycle to the extension step at a final extension of 10 minutes at 72。C. 
For all DOP-PCR products, the fragment sizes were checked by agarose gel 
electrophoresis and fragments between 100-800 bp were desirable. The 
yields were quantified by fluorometer (DyNA Quat 200, Hoefer, Pharmacia 
Biotech Inc.). 
b) CGH 
The procedure of CGH for DOP-PCR products was the same as for 
genomic DNA (see Section 2.4), except hybridization reaction was carried 
out in a moist chamber at 37°C for 3 days, instead of 2 days. Sex-
mismatched experiments were carried out as internal control. For external 
controls, negative control was the hybridization of differentially labeled 
amplified DNA from two normal individuals. Positive control experiments 
were performed on amplifying Xeno-666 and CNE-2, DNA, of which genetic 
imbalances in these samples were previously identified by conventional 
CGH. 
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4.2.2 Interphase FISH Analysis 
I) Materials 
a) NPC Biopsies 
Formalin-fixed paraffin-embedded NPC biopsies were provided by 
Professor K.F. To, Department of Anatomical and Cellular Pathology, The 
Chinese University of Hong Kong. 
A total 36 NPC tumor cases (NP1-NP36) were analysed by interphase 
FISH, including 33 primary biopsies (4 stage 11’ 3 stage III and 26 stage IV) 
and 3 recurrent tumors. Sections used in this part were as those used in 
Chapter 3. Due to tissue availability, case NP37 was not studied. 
b) Normal Nasal Epithelial Tissues 
Four cases of normal epithelial tissue were also provided and used to 
determine the cut-off value for the presence of significant polysomy of target 
probe regions in the tumor samples. 
b) Probes 
Digoxigenin-labeled chromosome-specific a-satellite probe 11 (D11Z1) 
and a region specific probe, lnt-2, (Oncor, Gaithersburg, Maryland) were 
employed in this study. The specificity of these probes was confirmed on 
normal metaphase spreads before interphase analysis (Figure 4.2). 
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Figure 4.2 Specificity test of FISH probes (a-satellite 11 and lnt-2) on 
normal metaphases. The hybridized probes were detected via FITC antibody 
as indicated by the yellow arrows. 
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II) Method 
Interphase FISH procedure was as described in Section 2.5 with minor 
modifications as follow: 
After a two-day hybridization, tissues sections hybridized with a-
satellite 11 probe were washed with 2x SSC for 5 minutes at 37°C. For lnt-2 
probe hybridization, sections were washed with 40% formamide/1.2x SSC, 
followed by 2x SSC for 5 minutes at 40°C. 
4.2.3 Statistical Analysis 
The correlation of copy number changes of a-satellite 11 and lnt-2 
with early stage (stage 丨 and III) and advanced stage (stage IV and local 
recurrence) of patients was assessed by two-tailed Fisher exact test. 
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4.3 Results 
4.3.1 CGH on Universally Amplified DNA 
I) External Control Experiments 
A comparison of the chromosomal imbalances detected between the 
DOP-PCR amplified CNE-2’ (Figure 4.3A) with conventional CGH (Figure 
4.3B) was carried out. DNA overrepresentations and underrepresentations in 
all chromosomal regions were identical between the original DNA sample 
and DOP-PCR products. No chromosomal aberrations were detected in the 
negative control experiment in Figure 4.3C. Both positive and negative 
controls indicated the DOP-PCR protocol was reliable and precise, and is 
applicable to the study of genetic alterations in microdissected tissues. 
II) Test Samples 
All 11 DOP-PCR amplified NPC samples (NP0-NP9 and CU19) were 
showed chromosomal aberrations (Figure 4.4A-K). The findings detected 
are tabulated in Table 4.1 and summarized in an ideogram (Figure 4.5). 
Frozen NPC biopsy (CU19) that was found no genetic imbalance in previous 
CGH study (Figure 4.4L) showed chromosomal aberrations after manual 
microdissection (Figure 4.4K). The copy number alterations in these 11 NPC 
samples were ranged from 2 aberrations in case NP6, which showed 
regional gains on chromosome 12 only, to 40 aberrations in NP9. Gains 
were more frequently detected than losses. The highest frequency of gain or 
amplification was involved the whole or part of chromosome 12q (9/11 
cases), with the smallest overlapping region (SOR) at 12q13. DNA 
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overrepresentations on 6p, 11q13, and 15q were also frequently found (8/11 
cases each). The minimal regions were at 6p21.2, 6p22, 11q13, and 15q22-
q23. Other common gains included 1q, 3q, 8q and 12p (7 /11 cases each), 
followed by 2q and 17q (6/11 cases each) and 20q (5/11 cases). The SORs 
were at 1q21, 3q26.3-qter, 8q12-q21.1, 8q23.2-q24.12, 12p12, 2q33, 17q 
and 20q11.2-q13.1. Consistent chromosomal loss was found on 11q14-qter 
(8/11 cases) with the minimal overlapping site on 11q21-q23. In 8 cases that 
revealed loss of distal of 11, a simultaneously overrepresentation of 11q13 
region was also observed, except NP8. Other common losses detected were 
14q (6/11 cases), 3p, 9p (5/11 cases each) and the SORs were mapped on 
14q31, 3p12-p14, 3p24-pter, and 9p22-pter. 
4.3.2 Interphase FISH Analysis 
I) Control Samples and Cut-off Values Determination 
FISH signals of a-satellite 11 and lnt-2 scored on normal nasal 
epithelial tissue sections are shown in Table 4.2. The cut-off levels (mean 
percentage+3 S.D.) for a-satellite 11 and lnt-2 were determined as 8.90% 
and 6.42% respectively. Examples of disomy FISH signals of these two 
probes are displayed in Figure 4.6. 
II) Paraffin-embedded Tissue Sections of NPC 
A total 36 NPC samples were studied by interphase FISH using a-
satellite 11 and lnt-2 probes. FISH findings of a-satellite 11 and lnt-2 in 36 
paraffin-embedded tissues of NPC are tabulated alongside the clinical 
disease staging of patients (Table 4.3). Eight out of 32 NPC cases (25%) 
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showed three or more a-satellite 11 signals. In contrast, a strikingly high 
incidence of lnt-2 copy number gain was found in 27 cases (75%). A 
simultaneously increment in a-satellite 11 copy number was also detected in 
these 8 cases. In particular, clustering of lnt-2 signals was observed in 6 
cases (NP1, NP5, NP14, NP20, NP30 and NP36). Examples of multiple 
copies of a-satellite 11 and lnt-2 signals in interphase nuclei of NPC are 
displayed in Figure 4.7. 
4.3.3 Statistical Analysis 
No significant correlation between copy number increase of a-satellite 
11 and lnt-2 and clinical disease stage, as suggested from the p value (> 
0.05) of two-tail Fisher exact test (Table 4.4). 
4.3.4 Comparison ofCGH and FISH Findings 
Eleven NPC cases (NP0-NP9 and CU19) were analysed by CGH. Of 
these, nine cases (NP1-N9) were also studied FISH interphase analysis. 
The CGH and FISH findings in these nine cases for a-satellites 7，8, 11, c-
myc, and lnt-2 could therefore be compared. However, since the centromeric 
regions were suppressed by human Cot-1 in CGH experiments, comparison 
was only possible on region specific probes (c-myc and lnt-2) and the 
corresponding CGH profiles on regions of 8q24 and 11q13 respectively 
(Table 4.5). Agreement of CGH and FISH findings was found in 11 out of 18 
incidences (concordance of 61.1%). CGH overrepresentations of 8q24 in 
NP7 and 11q13 in NP2 and NP4 did not show the corresponding c-myc and 
lnt-2 signal gains. In cases NP4, NP5 and NP6, significant c-myc population 
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was detected, but gain of 8q24 was not shown in the CGH profiles. Similarly, 
the presence of three or more lnt-2 signals was found in case NP8 with 
8.84% cell population, but was undetectable by CGH. 
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Figure 4.3. CGH profiles of positive control (CNE-2，）and negative control. 
The mean ratio profile (pink line) is obtained after digital imaging analysis and 
depicted with 95% confidence interval (yellow lines). Eight to 12 metaphases 
were analysed in each case. Vertical black line represents green to red ratio 
of 1.0. The first red and green lines next to the black line represent 
thresholds for chromosomal losses (0.75) and gains (1.25), respectively. The 
ratio profiles exceed 1.5 (the second green line) indicate the regions of high-
level copy gains. 
A) CNE-2'-PCR (Sex-mismatch). 
B) CNE-2’ (Sex-match). 
CGH profiles obtained from both CNE-2'-PCR and CNE-2’ were more or less 
the same. (This source of this CNE-2’ is different from that of CNE-2) 
Underrepresentations: 3p21.1-q12, 4p12-qter, 9p22-pter, 10p, 18’ 20p, Xq27-qter, Y. 
Overrepresentations: lpl3-p34.3, lq2l-q43, 2pl3-pter, 3p2l-pter, 3q13.1-qter, 5p, 
5q12-q31, 6p21.3-pter, 6q13-q26, 7, 8q,9p13-p21, 9q, 11q14-q23, 12q12-q24.1, 13, 16p, 
17q12-qter, 20q, 22q12-qter, Xp22.1-pter. 
C) Negative Control. No aberration was detected. 
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Figure 4.4. CGH profiles of NPC samples (NP0-NP9 and CU19). 
A. NPO 
Losses: 11q21-qter, 16q 
Gains: 8q12-q21.2, 8q23-q24.1, 11q12-q14, 15q21-q26.1 
B. NP1 
Losses: 3p, 11q14-qter 
Gains: 1q, 3q26.3-qter, 6p22-pter, 6q23-q24, 8p12-p22, 8q12-q24.1, 11q13, 12p-q24.2, 19p-
q13.3, 20p-q13.2, 22q11.2-q13.2 、 
Amplificaitons:1q21-q43, 12q21-q22 、 
C. NP2 
Losses: 8p22-pter, 9p-q21, 11q14-qter, 16q12.1-q21 
Gains: 1q, 2p14-p16, 2q32.2-q33, 3q26.1-qter, 6p21.1-pter, 6q23-q25, 8p21-qter, 11q12-13, 
12p-q24.2, 13q14, 15q21-q24, 17 
Amplifications: 12q13 
D. NP3 
Losses: 3p12-p14, 3p24-pter, 11q14-qter, 18q22-qter, Xp11.2-qter 
Gains: 1 p32-pter, 1q, 2p15-p16, 2q11.2-q14.1, 2q22-qter, 3q, 6p21.1-pter. 6q23-q25, 8q21.1-
q24.2, 9q22-qter, 10q21.2-q22.2, 11q12-q13, 12q13, 15q21-q24, 17q, 22q11.2-q13.2 
E. NP4 
Losses: 3p11-p14, 3p21.3-p24, 9p-q21, 9q31-q33, 13q21-qter, 14q13-qter 
Gains: 1q21-q23, 3q, 6p21.1-pter, 7q11.2, 7q22, 11q12-13, 12’ 15q15-q25, 17, 20q11.2-q13.1, 
21q22 
Amplifications: 3q26.3-qter, 12q13 
F. NP5 (Sex-match) 
Losses: 9p22-pter, 11q14-q23.1, 14q13-q21 
Gains: 6p21.2-p22, 7p11.2-q11.2, 9q32-qter, 12q13, 12q23-qter, 14q32, 15q22.3-q25, 17, 
20p11.21-qter, 21q22 
Amplifications: 11q12-13, 17q25 
G. NP6 
Gains: 12p12, 12q13-q21 
H. NP7 
Losses: 4p-q13, 4q22-qter, 9p, 11q23-qter, 13q21-qter, 14q13-q21, 14q24.3-qter, 16 
Gains: 1p22-p31.1, 1p32-p34.3, 1q, 2q22-qter, 3q23-q24, 3q26.2-qter, 5p12-q13, 5q23-q33. 
6p11.2-p23, 6q21-q25, 7p13-p21, 7q11.2-q33, 8q12-q21.1, 8q23.2-q24.1, 10p, 10q21-q25, 




Losses: 3p21-pter, 11q21-qter, 14q24-qter, 16q22-qter, 17p 
Gains: 2q32-q34, 3q26.1-qter, 5q11.2-q12, 6p11.2-p21.2, 6q23-q25, 15q15-qter 
J. NP9 
Losses: 3p12-p14, 3p24-pter, 4p15.1-p16.2, 4q12-q13, 4q22-qter, 5q14-q23.1, 5q32-q34, 6q11-
q15, 9p21-pter, 11q14-q23.1, 13q21-q22, 14q11.2-q21, 14q24.3-q31,Xp11.2-qter 
Gains: 1p33-pter, 1q21-q22, 1q32-q42, 2p14-p23, 2q33-qter, 3q26.3-qter, 6p11.2-pter, 7q11.2, 
8p22-qter, 9q34, 10p, 10q21-q24, 11q12-q13, 12p-q24.2, 13q14, 15q22-qter, 17p11.2-qter, 19, 
20,21q22, 22q 
Amplifications: 12p-q15. 15q22-q25, 17q, 19p13.2-pter, 22q12-q13.2 ‘ 
K. CU19 (microdissected) 
Losses: 14q31-qter 
Gains: 1q,2, 8, 12 
L. CU19 
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Table 4.2 Determination of cut-off values of a-satellite 
probe 11 and lnt-2 from four normal nasopharynx tissues 
A Probe a-satellite 11 
Case FISH Signals per Nucleus (。/。) 
"NPnormal| 0 1 2 3ormore 
95S6009~~ 3 M 2333 71.33 ^50 
95S6146 2.50 25.83 66.50 5.16 
95S6466 0.50 19.83 76.00 3.67 
95S6688 5.75 30.08 63.50 0.67 
Mean 3.15 24.77 69.33 2.75 
S.D. 2.21 4.31 5.49 2.05 
Mean+3S.D.| 9.78 37.71 85.81 8.90 
Cut-offValue: 8.90 
B. lnt-2 Probe (11q13) 
Case FISH Signals per Nucleus (。/。) 
NP normal 0 1 2 3 or more ‘ 
95S6803~~ ^ rTTz oTn ^ ^ 
95S6009 0.67 12.33 83.33 3.16 
95S6688 3.33 19.17 76.33 1.17 
95S5457 5.33 17.67 74.50 2.50 
Mean 3.04 15.09 79.08 2.67 
S.D. 1.91 3.93 4.33 1.25 
Mean+3S.D.| 8.78 26.87 92.06 6.42 
Cut-offValue: 6.42 
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Figure 4.6 Interphase FISH analysis using a-satellite 11 and lnt-2 on 
paraffin-embedded normal nasal epithelial tissues (X750). The nuclei were 
counterstained with PI, and the probes were tagged by FITC. 
A) Disomy signals of a-satellite 11 in case 95S6466. 
B) Two copies of lnt-2 per nucleus in case 95S6009. 
• • 
Table 4.3 Interphase FISH analysis using a-satellite probe 11 and lnt-2 on 
36 NPC patients. 
• Cases showing the percentage of three or more FISH signals per nucleus 
exceeded the cut-off values (8.90% for a-satellite 11 and 6.42% for lnt-2) 
are highlighted. Significant copy number gains of a-satellite probes 11 and 
lnt-2 were found in 8/32 and 27/36 cases. 
• Cases with frequent clustering signals of lnt-2 are in bold type. These cases 
include NP1, NP3, NP14, NP20, NP30 and NP36. 
• The hybridization efficiency of FISH experiment was reflected from the 
percentage of cells that contained no signals. All cases with zero FISH 
signals for each probe were below 10%, indicating the hybridization 
efficiency reached over 90%. 
• LR: local recurrence 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.7 Interphase FISH analysis using a-satellite 11 and lnt-2 on 
paraffin-embedded NPC biopsies (X750). The nuclei were counterstained 
with PI, and the probes were tagged by FITC. 
A) Trisomy signals of a-satellite 11 in case NP17. 
B) Trisomy signals of a-satellite 11 in case NP26. 
C) Cluster signals of lnt-2 in case NP1 • 
D) More than 10 copies per nucleus of lnt-2 case NP5. 
E) Copy number increment of lnt-2 was observed in case NP20. 
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Table 4.4 Correlation of copy number increment of FISH signals (a-satellite 
11and lnt-2) in NPC patients with their clinical stages bv Fisher exact test (2-
tailed) 
Numerical Early stage， Advanced p-value 
aberraAt Stage^ 
—PC-satellite 11— 0/6 8/26 0.296 
_ lnt-2 5/7 22/29 0.370 
1: UICC stages l-lll were categorized as early stage 
2: Advanced stage included stage IV and local recurrence 
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Table 4.5 CGH and FISH findings of c-myc (8q24) and lnt-2 (11q13) in 
nine NPC cases (NP1-NP9) 
Case C ^ ！ FiSH 0 ^ i RSH 
( 8 q 2 4 )丨（ c - m y c ) (11q13) | {lnt-2) 
NP1 + + + + 
NP2 + + + -
NP3 + + + + 
NP4 - + + -
NP5 - + + + 
i : 1 I 
NP6 - + - -
NP7 + - + + 
NP8 - - - + 
NP9 + + + + 
Concordance: 61.1% 
+: Aberration detected 
-:No aberration detected 
4 - 2 9 
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4.4 Discussion 
4.4.1 CGH Findings 
CGH revealed a number of genetic imbalances in 11 microdissected 
NPC biopsies studied. Recurrent chromosomal imbalances identified 
included gains on 1q, 2q, 3q, 6p, 8q, 11q13, 12, 15q, 17q and 20q, and 
losses on 3p, 9p, 11q14-qter and 14q. 
I) Comparison of Chromosomal Imbalances in NPC Biopsies and 
Cell Lines and Xenografts (Figure 4.8) 
Common aberrations were found between the cell lines and 
xenografts (see Chapter 3) and this NPC biopsy series. These included 
gains of 1q, 3q, 8q, 12q and 20q, and losses of 3p, 9p and 11q14-qter. 
However, frequent gains on 7p and deletion of chromosome 18q identified in 
cell lines and xenografts were uncommon in NPC biopsies. On the other 
hand, DNA overrepresentation of chromosomal regions on 11q13 and 17q 
were more common in the primary biopsies only. One possible explanation 
for the differences observed could be the selection for or against some 
clones during culture and cell passages. 
II) Comparison of the CGH Findings with the First CGH Report on 
NPC (Table 4.6) 
At the time of preparing this thesis, the first CGH report on NPC was 
published. In that paper, 25 primary and 26 recurrent tumors were analysed 
(Chen et al, 1999). The findings identified were compared with the reported 
4- 30 
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Figure 4.8 Comparison of frequent chromosomal imbalances in 
11 NPC biopsies and 3 cell lines and 3 xenografts. 
DNA sequences overrepresentations are shown by vertical line on the right 
hand side of chromosome ideogram, while underrepresentations are on the 
left. Black lines represent the CGH results of primary NPC, blue lines for 
xenografts, and orange lines for cell lines. 
Common changes: 
Gains: 1 q, 3q, 8q, 12q, and 20q. 
Losses: 3p, 9p and 1 lql4-qter. 
Differences: 
Frequent in NPC biopsies: Gains of iiqi3and 17q 
Frequent in cell lines and xenografts: Gain on 7p and loss of 18q 
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Table 4.6 Comparison of frequent chromosomal imbalances 
in NPC with the previous report 
Present study Chen et al 1999 
Imbalance Frequencv SOR Frequency SOR 
Chromosomal Overrepresentations 
+1q 64% 1q21-q22 47% 1q21-q22 
+11q 73% 11q13 41% 11q13 
+12p 64% 12p12 59% 12p12-p13 
+12q 82% 12q13 35% 12q13 
+17q 55% 17q 47% 17q21, 17q25 
Chromosomal Underrepresentations 
-3p 45% 3p12-p14, 53% 3p12-p14, 
3p24-pter 3p25-p26 
-9p 45% 9p22-pter 41% 9p21-p23 
-11q 73% 11q21-q23 29% 11q14-q23 
-14q 55% 14q31 35% 14q12-q21 
SOR: smallest overlapping region 
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CGH data and highlighted those common chromosomal alterations. These 
genetic changes include over-representations of 1q, 11q13, 12, and 17, and 
losses of 3p, 9p, 11q14-qter, and 14q. Although gains of 2q, 3q, 6p, 8q, 15q 
and 20q were detected at a lower incidence in Chen et al (1999) study, these 
changes were over-represented more frequently in this study. Common 
changes identified in both studies may be indicative of genetic alterations 
associated in NPC pathogenesis. In this section, chromosomal gains and 
losses are discussed in the order of chromosomal number. 
a) Chromosomal Regions Involved in Gains and Amplifications 
Chromosome 1q 
Gain of 1q was found in 64% (7/11 cases) of NPC biopsies studied. Besides 
NPC, gain or high level amplification 1q is common in sacromas (Szymanska 
et al, 1997; Forus et al, 1996 & 1998; Armengol et al, 1997) as well as other 
solid tumors, such as hepatocellular carcinoma O^ong et al, 1999), renal 
clear cell carcinoma (Gronwald et al, 1997) and mesothelioma (Bjorkquist et 
al, 1997). In both Chen et al (1999) and this study, the smallest overlapping 
site in NPC has been mapped on 1q21-q22, which coincided with the 
amplicon identified in hepatocelluar carcinoma, sarcoma, and renal 
carcinoma. This amplicon contains several potentially important genes, 
including the octamer-binding transcription factor (OTF1) gene and the 
neurotrophic tyrosin kinase receptor type-1 (NTRK1) gene. Using molecular 
analysis, the 1q amplicon in human sarcoma has been characterized. Genes 
such as FLG, SPRR3, and CACY, are suggested to be frequently involved in 
sarcoma (Forus et al, 1996). The CACY (Calcyclin), encoding a member of 
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S100A family of calcium binding protein, a cell-cycle-regulated protein that 
has been suggested to be associated with metastatic behavior of tumor cells 
(Weterman et al, 1992). 
Chromosome 2q 
Gain of chromosome 2q was detected in 6/11 NPC biopsies with 
minimal region of overlap at 2q33. This aberration is uncommon in many 
types of cancer and the involvement of candidate genes residing in this 
region and NPC development is unknown. 
Chromosome 3q 
Overrepresentations of 3q has been found (64%), with the smallest 
common gained or amplified region at 3q26.3-qter. Overrepresentations of 
distal 3q have been detected in many tumor types, including head and neck 
squamous cell carcinoma (HNSCC) (Speicher et al, 1995), oral squamous cell 
carcinoma (OSCC) (Hermsen et al, 1997)，cervical squamous cell carcinoma 
(Heselmeyer et al, 1997) and lung cancers (Peterson et al, 1997). These 
findings suggest the presence of one or more genes that are important for the 
development of tumor. The locus of the human telomerase RNA gene (HTR) 
at 3q26.3 is within the S〇R identified in this NPC series. This gene has been 
found to be amplified in cervical carcinoma and its role has been proposed to 
be essential for immortalization (Soder et al, 1997). Oncogene bcl-6 at 3q27 
was found to be amplified in marginal zone B-cell neoplasms (Dierlamm et al, 
1997). This gene might also involve in NPC tumorigenesis. 
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Chromosome 6p 
Frequent gain of 6p (73%) has been detected in this series of NPC, but 
was uncommon in the previous CGH report (Chen et al, 1999). In here, two 
SORs, 6p21.2 and 6p22-p23, have been mapped. Gain or amplification of 
6p21-pter has been described in mesothelioma (Kivipensas et al, 1996)， 
glioma (Weber et al, 1996), and ovarian carcinoma (Tapper et al, 1997). DNA 
sequence over-representations in this region is possibly related to NRASL3, 
which belongs to the RAS superfamily. 
Chromosome 8q 
Frequent of chromosome 8q gain was detected not only in primary NPC 
(64%), but also in xenografts and cell lines (see Chapter 3). These findings 
suggested overrepresentation of chromosome 8 might represent primary 
genetic aberrations that had been carried through clonal evolution in primary 
NPC and maintained in in vitro. 
The incidence of a-satellite 8 and putative c-myc oncogene in NPC has 
been investigated in paraffin-embedded NPC biopsies. Copy number 
increments of a-satellite 8 and c-myc were detected in 43% and 60% NPC 
cases respectively. The involvement of 8q gain and c-myc has been 
discussed in Chapter 3. 
Chromosome 11q 
Eight out of the 11 (73%) microdissected NPC biopsies showed an 
increase of DNA sequences copy number in the band 11q13 by CGH assay. 
This finding agreed with the Chen et al report. Using CGH, over-
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representation of 11q13 has also been detected by CGH in HNSCC 
(Bockmuhl et al, 1996 & 1998), OSCC (Wolff et al, 1998; Gebhart et al, 
1998), and breast carcinoma (Tanner et al, 1998). These findings suggested 
the involvement of protooncogenes in the11q13 region in tumorigenesis. 
Candidate oncogenes in this region include lnt-2, cyclinD1, Ems-1, Hst-1 and 
Bcl-1. The possible involvement of lnt-2 was further investigated by 
interphase FISH and is discussed in Section 4.4.2. 
Chromosome 12 
Consistent copy number gain and high level amplification of the entire 
or part of chromosome 12 was found in 9 out of 11 primary NPC. 
Overrepresentation of chromosome 12 occurred more frequently on the long 
arm (82%) than the short arm (64%) as shown in the 11 primary NPC 
studied, suggesting a more important role of 12q gain in the NPC 
development. 
12p 
In this study, the smallest overlapping region identified on 12p was 
12p12. Protooncogene K-ras is mapped to this region. The overexpression 
of ras protein, p21, has been detected in 76% primary NPC (Porter et al, 
1994), however, the expression of p21 in the 11 NPC samples studied is not 
known. 
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12q 
Amplicon SOR 12q13-15 identified contains a number of oncogenes 
and genes that are involved in cell cycle regulation. Two of these genes, 
CDK-4 (cyclin-dependent kinase 4) and MDM2 (mouse double minute 2), 
have been reported to be frequently amplified in glioma (Sonoda et al, 1995) 
and sarcoma (Khatib et al, 1993). Excessive expression of these 
oncoproteins destabilizes the cell cycle regulation and leads to uncontrolled 
cell proliferation. MDM2 amplification in NPC, however, was found in only 1 
out 46 NPC samples as reported in a previous southern blot study (Qian et 
al, 1995). 
Chromosome 15q 
Gain of chromosome 15q was common in this series of primary NPC 
(73%). On the contrary, Chen et al (1999) have not detected this aberration 
in the 25 primary NPC samples analysed. Also, gain of 15q is rare in most 
cancer with no putative oncogene site described. Further investigations are 
necessary to verify the novel finding on the minimal region 15q22-24 and 
NPC development. 
Chromosome 17q 
Overrepresentation of 17q has been found in 55% of NPC studied. 
This aberration has also been demonstrated in neuorblastoma (Plantaz et al, 
1997), HNSCC (Bockmuhl et al, 1996), and gastric carcinomas (Kokkola et 
al, 1997). Chromosome 17q contains genes that are known to be involved in 
tumorigenesis. These genes include GAS (Gastrin), ERBB2 and nm23 
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genes. GAS stimulates the growth of gastic and colon carcinoma cell line in 
vitro (Waston et al, 1989). ERBB2 has been demonstrated to be amplified 
and overexpressed in a proportion of gastric carcinomas (Tahara, 1995). 
Genes nm23, which encode proteins with nucleotide diphosphate kinase 
activity and have been found in aggressive neuroblastomas (Leone et al, 
1993). These genes, therefore, might also be responsible for the NPC 
development. 
Chromosome 20q 
Gains of 20q was identified in 5/11 NPC biopsies with minimal 
overlapping region on 20q11.2-q13.1. Overrepresentation of 20q has been 
reported in breast (Kallioniemi et al, 1995) and stomach cancers (Kokkola et 
al, 1997). A number of candidate genes, such as MYBL2 and PTPN1, are 
located within the region 20q11.2-q13.1. MYBL2, at 20q13, encodes a 
transcription factor and plays an important role in cell cycle progression 
(Noben-Trauth et al, 1996). PTPN1 encodes a nonreceptor tyrosine 
phosphate and is involved in growth regulation (Hashimoto et al, 1992). 
b) Chromosomal Regions Involved in Deletions 
Chromosomal 3p 
In concordance with previous CGH and LOH findings in NPC, this 
present CGH analysis on 11 NPC biopsies revealed frequent losses on 3p 
(45%). Loss of 3p is also common in HNSCC (Bockmuhl et al, 1998)，OSCC 
(Wu et al, 1994), and renal cell carcinoma (Moch et ai, 1996). Previous 
molecular studies have identified three distinct deletion regions in primary 
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NPC, 3p13-14.3, 3p14.3-3p21, and 3p21.3-pter (Lo et al, 1994). Studies on 
the candidate tumor suppressor gene, VHL (on 3p25), have however 
indicated the lack of involvement of this gene in NPC (Sun et al, 1995). Ohta 
et al (1996) has identified a novel gene FHIT (fragile histidine triad gene) at 
3p14.2 within which fragile site FRA3B locates. Homozygous deletion and 
aberrant expression of the FHIT have been identified in two NPC cell lines. 
Also, Cheng et al (1998) have demonstrated the growth suppressive function 
of 3p21 in an NPC cell line by monochromosome transfer. Although this 
locus is outside the minimal deleted DNA sequences (3p12-p14 and 3p24-
qter) detected in this study, the presence of TSG in 3p21 has clearly been 
demonstrated. 
Chromosome 9p 
Deletion of 9p was found in 5 out of 11 primary NPC tumors (45%), 
which was also consistent with previous LOH findings (Huang et al, 1994; 
Mutirangura et al, 1997). The present CGH analysis revealed the minimal 
deleted region on 9p22-qter, which overlap with the SOR, 9p21-p23, 
identified in the previous CGH study (Chen et al, 1999). Two known TSGs， 
p16 and p15, which within 9p21-22, encode the negative regulator proteins 
for the cell cycle progression. The p16 or p15 protein binds to CDK4 and 
CDK6 and inhibits the CDK4/cyclinD-dependent phosphorylation of Rb 
protein, which in turn inhibits the cell cycle progression from G1 to S phase. 
Loss of normal function of p16 will lead to cell progression and proliferation 
(Liggett et al, 1998). The inactivation of p16 has been found in primary NPC 
as well as NPC cell lines and xenografts. Further investigations have 
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suggested homozygous deletion and aberrant methylation account for the 
predominant mechanism of p16 inactivation in NPC (Lo et al, 1995, 1996; 
Sun et al, 1995). Another possible TSG, p15, maps approximately 20 kb 
below the locus to p16. However, Lo et al (1997) found that p15 loss was not 
detected in NPC. 
Chromosome 11q 
Loss of 11q14-qter was identified in 8 out of 11 primary NPC tumors. 
This aberration was also detected in three NPC xenografts and one cell line 
studied by CGH (Figure 4.8). The frequent deletion of distal 11q detected, in 
particular 11q21-q23, is in agreement of previous LOH studies (Hui et al, 1996; 
Mutirangura et al, 1997). Common loss of 11q14-q24 and 11q22 has been 
reported in chronic lymhocytic leukemia (Karhu et al, 1997) and mantle cell 
lymphoma (Monni et al, 1998) respectively, suggesting the presence of TSG(s) 
on distal arm of 11q. A putative TSG, Ataxia Telangiectasia mutated (ATM) 
gene, which maps to 11q22-q23, is involved Ataxia-telangiectasia (AT) (Gatti 
et al, 1991). AT is a cancer-predisposing syndrome with DNA repair 
deficiency. Previous studies have suggested the risk of cancer development 
in patients with AT is about 100 times higher than in non-AT individuals 
(Morrell et al, 1986). However, the role of ATM gene in the development of 
NPC remained unknown. 
Loss of DNA material from distal 11q was frequently accompanied by 
11q13 overrepresentation in this series of sample. A similar pattern of DNA 
changes was frequently observed in HNSCC (BockmuN et ai, 1998; Jin et al, 
1998). 
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Chromosome 14q 
Chromosome 14q was the second most frequently deleted site in the 
11 primary NPC (55%). This finding is consistent with the previous LOH 
studies (Cheng et al, 1997; Mutirangura et al, 1998). Other tumors, such as 
renal cell carcinoma (Moch et al, 1996)，mesothelioma ( B j o r _ s t et al, 1997; 
Kivipensas et al, 1996), and neuroblastoma (Plantaz et al, 1997), also 
exhibited loss on 14q. The present CGH analysis identified the smallest 
common region of on 14q being 14q31. A possible candidate gene residing 
within this region is TSHR, which has been suggested in the carcinogenesis 
of adenocarcinomas of thyroid gland (Bronnegard et al, 1994). 
4.4.2 Interphase FISH Analysis 
To further investigate the involvement of peri-centromeric area of 
chromosome 11 and lnt-2 gene in NPC tumorigenesis, interphase FISH was 
performed on 36 paraffin-embedded NPC biopsies. A strikingly high 
incidence of lnt-2 gains was observed in 27 out of 36 cases (75%). This 
strongly suggested an involvement of lnt-2 amplification in the NPC 
tumorigenesis. Of these 27 cases, clustering of lnt-2 signals was displayed 
in 6 cases and gain at a-satellite 11 was present in only 8 cases. These 
observations suggested lnt-2 amplification could occur as an independent 
event in NPC tumorigenesis. Clusters of lnt-2 signals (Figure 4.7C-F) might 
be suggestive of the homogenously staining regions (HSRs) in the 
cytogenetic manifestation. Lese et al (1995) demonstrated a good 
correlation between cytogenetically identified HSR on 11q13 and co-
amplification of oncogenes lnt-2 and Hst-1 in OSCC cell lines. 
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lnt-2 gene was first described as a frequent integration site for mouse 
mammary tumor virus. It encodes fibroblast growth factor (FGF)-3, a growth 
factor member of FGF family. The FGF-3 is homologous to basic (b) FGF, 
which has been implicated in cell proliferation, morphogenesis and 
differentiation. Previous studies have demonstrated that the expression of 
lnt-2 was primarily restricted to prenatal mouse development. Using in situ 
hybridization, RNA transcripts of lnt-2 was found at a wide variety of sites in 
mouse embryo at specific times, indicating that lnt-2 expression was tightly 
regulated both temporally and spatially (Jakobovits et al, 1986; Wilkinson et 
al, 1988 & 1989). In vivo, lnt-2 expression has been suggested to induce 
mammary hyperplasia and occasionally cause carcinoma in breast tissue of 
transgenic mice (Muller et al, 1990). The tumorgenic role of lnt-2 was further 
strengthened by nude mice studies. After orthotopic implantation of FGF-
expressing cells, tumors formation has been resulted (Hajiton and Calberg-
Bacq, 1995). In vitro, FGF-3 has growth factor-like activity. Overexpression 
of FGF-3 stimulates cell proliferation in serum-free medium and induces 
anchorage-independent colony formation in soft agar. 
Amplification of lnt-2, has been reported in various human carcinomas, 
including HNSCC (Rubin et al, 1995; Somers et al, 1990), larynx squamous 
cell carcinoma (Miyahara et al, 1998), esophageal carcinoma (Shimada et al, 
1997; lkeda et al, 1996), breast carcinoma (Seshadri et al, 1996; Fioravanti et 
al, 1997; Hui et al, 1997), ovarian carcinoma (Sasano et al, 1990) and OSCC 
cell lines (Gebhart et al, 1998). 
The region of 11q13 is a complex amplicon containing multiple 
amplification units. Besides lnt-2, several putative oncogenes, such as Bcl-1, 
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cyclin D1, Hst-1, and Ems-1, are located. Co-amplification of lnt-2 and Hst-1 
has been reported in esophageal carcinoma (Tsuda et al, 1989), while 
amplification of lnt-2, Ems-1 and Bcl-1, have been identified to be amplified in 
breast carcinoma (Hui et al, 1997), and larynx squamous cell carcinoma 
(Miyahara et al, 1998). These findings suggest lnt-2 might not be the sole 
"driver" gene for the NPC development. The possible involvement of other 
genes on 11q13, known or unidentified, could not be ruled out. 
In this study, no significant correlation between copy number gain of lnt-
2 or a-satellite 11 with clinical tumor staging of NPC was noted. However, in 
the 3 local recurred tumors, consistent lnt-2 gain was observed. This might 
imply that lnt-2 could be associated with recurrent NPC. 
4.4.3 Comparison of CGH and FISH Findings 
Nine NPC cases (NP1-NP9) were analysed by both CGH findings and 
interphase cytogenetics, and 61.1% concordance was found. DNA 
sequences gain on 11q13 in cases NP2 and NP4, as indicated by CGH, did 
not show lnt-2 gain. Since the size of affected regions spans over 2.5 to 5 
Mb, the involvement of other protooncogenes, such as Bcl-1, cyclin D1, Hst-
1, and Ems-1, within the same loci cannot be ruled out. Amplifications of 
these genes have been detected in breast carcinoma (Tanner et al, 1998; 
Hui et al, 1997), hepatocelluar carcinoma (Zhang et al, 1993) and HNSCC 
(lzzo et al, 1998; Patel et al, 1996). The discrepancy might be attributed by 
amplification of these genes in CGH analysis. Similarly, CGH revealed gain 
on 8q24 in NP7 might indicate gene(s), other than c-myc, involve in NPC 
development. 
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Case NP8 showed numerical increment of lnt-2 gene (8.84% of cells 
scored) by interphase FISH analysis, but the fluorescence ratio increase at 
the band 11q13 was not detected by CGH. This might due to the presence 
of lnt-2 in a subpopulation of cells that precluded the CGH detection. A 
similar explanation was also applied on the disagreement of CGH and FISH 
in c-myc (8q24) detection in cases NP4, NP5 and NP6. The present study 
demonstrated the usefulness of interphase FISH analysis in overcoming the 
limitation of CGH in the detection of subtle changes in a mixed cell 
population. 
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4.5 Summary of This Chapter 
In this part of study, the combination of microdissection, DOP-PCR, and 
CGH was employed. A pattern of chromosomal gains (1q, 2q, 3q, 6p, 8q, 
11q13, 12’ 15q, 17, and 20q) and losses (3p, 9p, 11q14-qter and 14q) were 
identified. Most genetic alterations detected are consistent with previous CGH 
• 
and LOH studies. The salient features of this study are the comparison of 
frequent gains and losses between biopsies and cell lines and xenografts, and 
the identification of genetic changes previously not reported in NPC. 
Overrepresentation of 11q13 region, which was frequently identified in 
present and the previous CGH study, was further investigated by interphase 
FISH analysis. Multiple copies of lnt-2 were observed in 75% of this series 
NPC cases. Interphase FISH confirmed the CGH results and the involvement 
of lnt-2 in NPC carcinogenesis. Also, its usefulness in the detection of genetic 
aberrations in admixed cells population was demonstrated. 
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Chapter 5 Conclusion and Further Studies 
5.1 Conclusion 
In the first part of this thesis, CGH analysis on NPC biopsies was 
hampered by normal cell contamination. NPC-related chromosomal 
aberrations were therefore determined from NPC cell lines and xenografts 
instead. CGH revealed several genetic changes in these immortalized 
samples that have not been previously identified by conventional cytogenetics. 
Gains of chromosomes 7 and 8’ which were frequent detected, together with 
c-myc on 8q24 were further investigated by interphase cytogenetics on a large 
series of paraffin-embedded tissue sections from NPC patients. 
In the second part, the combination of microdissection and universal 
DNA amplification by DOP-PCR enabled CGH analysis on 11 primary NPC. A 
pattern of chromosomal gains (1q, 2q, 3q, 6p, 8q, 11q13, 12, 15q, 17q, 20q) 
and losses (3p, 9p, 11q14-qter, and 14q) was identified. The initiation and 
progression of NPC is likely a consequence of interaction of activated 
oncogenes on gained chromosomal regions, together with inactivated TSGs 
on deleted chromosomal sites. Most genetic alterations detected were 
consistent with previous LOH and CGH findings. Several genetic imbalances 
were novel. Genetic aberrations such as gains of chromosomes 8 and 12, 
were identified in primary NPC, cell lines and xenografts. Chromosome 7 gain 
was more frequent in cell lines and xenografts, while overrepresentation of 
11q13was recurrent in primary NPC. The involvement of chromosome 11 and 
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lnt-2 on 11q13, in NPC development was also assessed on the same series of 
tissue sections. 
Three or more copies of a-satellites 7’ 8 and 11 were observed in 27%, 
43% and 25% respectively. Multiple copies of c-myc (60%) and lnt-2 (75%) 
were found at a higher frequency. In the present series, we were unable to 
discern obvious correlation between copy number increase a-satellites 7’ 8 
and 11, c-myc and lnt-2 with clinical tumor staging of patients studied. 
Nevertheless, the frequent c-myc and lnt-2 amplifications detected suggested 
the importance of these oncogenes in the NPC carcinogenesis. 
The efficacy of DOP-PCR technique in amplifying small quantity of 
DNA, from biopsies or archived materials, for genetic analysis has been 
demonstrated in this thesis. Using interphase FISH, our CGH findings on 
DOP-PCR amplified DNA were confirmed. The usefulness of interphase 
FISH in overcoming the limitation of CGH in the detection of subtle changes 
in a mixed cell population was also demonstrated. 
The overall genomic alterations and the involvement of c-myc and lnt-2 
described in this thesis should provide entry points for further investigations in 
the understanding of NPC pathogenesis. 
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5.2 Further Studies 
5.2.1 Combination of Microdissection, DOP-PCR, and CGH 
The combination of microdissection, DOP-PCR and CGH, has 
enabled the examination of overall genetic changes in 11 NPC biopsies. For 
further investigations, a larger series of NPC patients can be studied in a 
similar approach. Chromosomal imbalances patterns revealed from different 
stages might indicate the pathway of NPC initiation and progression. In 
addition, NPC tumor of primary and recurrent from the same patient can be 
investigated in pair, thus revealing aberrations related to recurrent NPC. 
5.2.2 Multicolor Karyotyping 
In addition to amplification and deletion, chromosomal 
rearrangements, such as translocation and inversion, may also play a pivotal 
role in oncogene activation or TSGs inactivation in tumor. The balanced 
chromosomal rearrangements present in the NPC genome are undetected by 
CGH. Spectral karyotyping (SKY) is a newly developed molecular 
cytogenetic technique which allows the detection chromosomal origins of 
markers, subtle translocation or complex chromosomal rearrangement of 
tumor cells (Schrock et al, 1997). SKY can be applied to the study of 
structural rearrangements in NPC. However, this study is highly dependent 
on metaphase of tumor ceils. NPC cell lines, of which quality metaphases 
can be obtained more easily, should be the prior and valuable targets for 
investigations. Since short-term culture of primary NPC has a low successful 
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rate, direct harvesting of NPC tissues for tumor metaphases can be 
attempted. 
5.2.3 Microarrays 
Consensus regions of gains including significant high level 
amplifications have been noted in the present investigation at 1q, 3q26-qter, 
11q13, 12p, 12q13, 15q22-25 and 17q. Although amplification of lnt-2 gene 
on 11q13 and c-myc gene has been studied, other candidate oncogenes on 
these amplicons await identification. DNA sequences on 11q14-qter, 3p, 9p 
and 14q have been frequently detected and putative TSGs that undergo 
allelic loss remain to be characterized. 
To fine map these amplified regions, such as 12q13, and deleted sites 
like 11q14-qter, higher resolution CGH array can be employed. Instead of 
metaphase chromosomes, the DNA targets for hybridization are replaced 
with a set of nucleic acid sequences on microchips. The sets of target DNA 
can be derived from cloning of the interested DNA fragments into bacterial 
artificial chromosome (BAC), yeast artificial chromosome (YAC), cosmid, or 
P1-derived artificial chromosome (PAC) vectors. All protooncogenes and 
TSGs can also be designed as the targets. It is possible to identified NPC-
related genes. Alternatively, the abnormal expression of particular genes in 
NPC can be revealed when cDNA library is used as array target. 
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